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ABSTRACT 
The existence of an ultrashort feedback mechanism regulating GnRH secretion has 
been supported from in vivo and in vitro studies. However, the complex synaptic 
connections of GnRH neurons with other neural elements made it difficult to determine 
whether the regulation was mediated by direct actions on the GnRH neurons or 
through actions on other interneurons. The recent development of the GnRH-secreting 
neuronal cell line, GT1, provided a model system for the study of neural regulation of 
a pure population of GnRH neurons. The present studies utilized GT1 -7 cells to 
investigate whether GnRH (at the level of the nerve terminal) influences the control of 
its own release. 
Preliminary studies determined the presence of GnRH mRNA in GT1-7 cells and 
established a cell culture system for the analysis of secretagogue-induced GnRH 
release. In this system GnRH release was shown to be spontaneous and was 
enhanced by the addition of K+, L-GLU, forskolin and PMA. Furthermore, K+- and 
forskolin-induced GnRH release was dependent on extracellular Ca
2+. For the analysis 
of an ultrashort feedback mechanism, GT1-7 cells were cultured in 6-well plates to 
near confluence and then incubated in serum-free medium in the presence (1 nM-
1 µM) or absence of GnRH antagonist, Ant 27. Basal, K+-and forskolin-induced 
secretion of GnRH was monitored with antiserum 1076 which does not cross-react 
with Ant 27 at> 1 µM. Ant 27 treatment increased basal, K+- and forskolin-stimulated 
GnRH release in a dose-dependent manner. Total content was unaffected by 18 h 
treatment of GT1-7 cells with Ant 27. This suggests that the effects of Ant 27 are at 
the level of release and not biosynthesis. The presence of GnRH binding sites in the 
cells was demonstrated with 1251-GnRH analog. These findings support the concept 
that GnRH, acting via autoreceptors, negatively controls its own release. 
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1: NEURAL REGULATION OF GnRH BIOSYNTHESIS 
AND RELEASE 
1.1 INTRODUCTION 
Gonadotropin-releasing hormone (GnRH) is a hypothalamic decapeptide that plays a 
pivotal role in controlling reproduction in a variety of animal species. GnRH acts on 
the anterior pituitary gland to stimulate the biosynthesis and release of the 
gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH). 
These hormones in turn stimulate gonadal steroidogenesis and gametogenesis. The 
steroids feed back at the pituitary and the hypothalamus to modulate further 
production of the gonadotropins and GnRH (Schally, 1978; Millar et al., 1987). 
GnRH perikarya have been localized in several brain regions, but are concentrated in 
the ventral forebrain. Here, cells are dispersed in several areas including the diagonal 
band of Broca (DBB}, stria terminalis, medial preoptic area (POA), lateral POA, 
periventricular POA, and the ventral portions of the medial and lateral septal nuclei 
(Kalra and Kalra, 1983; Silverman, 1988). GnRH is synthesized as part of a larger 
prohormone in neuronal cell bodies, especially in the medial POA and the 
suprachiasmatic area. The human prohormone contains the sequence for GnRH and 
a sequence of 56 amino acids called GnRH-associated peptide (GAP) (Seaburg and 
Adelman, 1984). Following processing of the prohormone within the neurosecretory 
granules, GnRH is released into the hypophyseal portal circulation from nerve 
terminals within the median eminence (ME). This release is pulsatile and obligatory 
to pulsatile LH release. Control is exerted by neural pathways in the central nervous 
system (CNS) which converge onto the GnRH-secreting cells (Schally et al., 1971; 
Knobil, 1980; Rangaraju eta/., 1991). The localization of GnRH and GnRH receptors 
in extrahypothalamic brain areas suggests that, in addition to being the regulator of 
LH and FSH release, GnRH might act as a central neuromodulator (Kalra and Kalra, 
1983; Reubi and Maurer, 1984). 
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This literature review will discuss the neural systems which are responsible for the 
regulation of hypothalamic GnRH biosynthesis and release. The essence of the thesis 
describes an investigation into the role of GnRH in modulating its own secretion. 
1.2 FACTORS REGULATING GnRH BIOSYNTHESIS AND RELEASE 
Neuroendocrine regulation of GnRH secretion is the central control point in the 
complex modulation of gonadal function at all stages of life. These include the 
transitional states of puberty and seasonal or ovarian cyclicity (Wildt et al., 1980; 
Lincoln and Short, 1980; Knobil, 1980). Various modulatory hormonal and neural 
inputs act to influence the amplitude/ frequency characteristics of GnRH discharge or 
to provide a II permissive milieu II that allows the GnRH neurons to produce and 
discharge optimal levels of neurohormone with inherent periodicity (Kalra and Kalra, 
1983). 
In several species the neuroendocrine mechanisms of pubertal development involve 
the integration of various processes at the levels of the hypothalamus, pituitary and 
gonads which occur at different times during the prepubertal period. These, in turn 
result in the culmination of a multitude of hormonal and anatomical developmental 
changes. A number of neuronal factors are implicated in the maturation of the GnRH 
surge centre. The final component elicits the increased frequency of pulsatile GnRH 
secretion responsible for triggering the prepubertal LH surge (Ojeda et al., 1980; 
Bourguignon and Franchimont, 1984). 
The GnRH neuron receives a sparse but chemically diverse synaptic input which 
includes the following: 
1.2.1 NEUROTRANSMITTERS 
CATECHOLAMINES (CA) 
Subsequent to the initial observations that dibenamine, an a-adrenergic antagonist, 
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blocks ovulation in the rabbit, numerous investigators have suggested a role for CA 
in the reproductive process (Sawyer et al., 1947; McCann et al., 1975; Negro-Vilar et 
al., 1979). CA terminals directly innervate GnRH neurons, providing the anatomical 
substrate for CA modulation of GnRH secretion, although neither norepinephrine nor 
dopamine is localized within GnRH neurons (Ajika, 1979; Hoffman et al., 1982; Chen 
et al., 1989a). 
It is widely accepted that certain neuromodulators convey information regarding the 
steroidal milieu to the GnRH neurons, since few if any GnRH neurons concentrate 
steroids or contain steroid receptors (Shivers et al., 1983; Bicknell, 1985; Herbison and 
Theodosis, 1992). Interestingly, CA neurons are capable of concentrating steroids 
raising the possibility that they may mediate GnRH release in response to changes in 
sex steroid levels (Sar and Stumpf, 1981; Sar, 1984). Further evidence to support this 
view are the findings by Moguilevsky et al. (1990) who showed that the effect of CA 
on GnRH- induced LH secretion changes from inhibition to stimulation during sexual 
maturation in the female rat. They postulate that these changes are related to 
modifications in the response of the CA neurons to ovarian hormones. 
NOREPINEPHRINE (NE) 
The GnRH cell bodies in the POA of the rat hypothalamus lie in close apposition to 
noradrenergic fibres which originate in the medulla and the locus ceruleus. This 
anatomical association supports the involvement of NE in modulating GnRH release 
(Palkovits, 1981; Hoffman et al., 1982). 
Ramirez et al. (1986) monitored pulsatile GnRH release by means of push-pull 
cannulae (PPC) implanted in the hypothalami of conscious, unrestrained female 
rabbits. Their data showed that infusion of NE (100 nM - 1 µM) induced a 2-fold 
increase in GnRH release. In a similar study, perfusion of NE into the medial basal 
hypothalamus (MBH) stimulated GnRH release, which is accompanied by an increase 
in plasma LH, in estradiol (E2)-treated ovariectomized (OVX) rabbits, but not OVX 
rabbits (Pau and Spies, 1986). In vivo experiments by Terasawa et al. (1988) 
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demonstrated that NE acting through an a.1-adrenergic receptor stimulates pulsatile 
GnRH release in OVX rhesus monkeys, questioning the involvement of ovarian 
steroids in mediating this effect. In support of this observation Jarry et al. (1990) 
showed that NE via an a.1-adrenergic mechanism in the preoptic/anterior hypothalamus 
but not MBH is required to drive the GnRH pulse generator in OVX rats. Furthermore, 
studies by Levine et al. (1991) showed that treatment with an a.1-adrenergic antagonist 
reduced GnRH pulse generator activity in OVX rats, but was ineffective in gonadally 
intact female rats. Their explanation for this observation is that the ovarian hormones 
suppress the activity of the GnRH pulse generator by inhibiting NE synaptic 
transmission. 
The literature is thus inconsistent regarding the effects of ovariectomy and ovarian 
steroid treatment on NE stimulated GnRH release. 
Gore and Terasawa (1991) investigated whether changes in NE input to the GnRH 
neurosecretory system of female rhesus monkeys contributed to the known pubertal 
increase in GnRH release. Their results showed that the response of the prepubertal 
group to a.1-adrenoceptor stimulation was significantly greater than those of the older 
age groups. Secondly, they found that NE release increased significantly from the 
pre- and early pubertal to the midpubertal stage. These results lead them to propose 
that the increase in NE release during puberty contributes to the developmental 
increase in GnRH release. 
Leposavic et al. (1990) using an in vitro superfusion system demonstrated that an a.1-
agonist stimulated GnRH release from hypothalami from adult and peripubertal rats 
but inhibited the secretion from the limited stores available in hypothalami from 
immature rats. Hypothalami from castrated adult rats responded with a marked 
reduction in GnRH release to a.1-adrenoceptor stimulation in vitro. These results were 
similar to the in vivo stimulation of immature rats and support a role for testosterone 
(T) in this response. Binding studies revealed a striking increase in the density of a.1-
and P-adrenoceptor binding sites in the adult but failed to demonstrate concomitant 
age-related changes in ~-adrenoceptor binding. In addition to the above mentioned 
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proposal by Gore and Terasawa (1991 ), these observations raise the possibility that 
alterations in the nature of the GnRH response to a.1-adrenoceptor stimulation may be 
a contributory factor in the initiation of puberty. 
Besides the effects on GnRH release, Weesner et al. (1991) showed that the 
administration of an a.1-adrenergic antagonist into the POA of OVX rats suppressed 
levels of GnRH messenger RNA (mRNA). Further studies by the same group have 
suggested that NE, acting through an a.1-adrenoceptor, is a mediator of the stimulatory 
effects of estrogen on GnRH biosynthesis and release and subsequent LH release 
(Weesner et al., 1993). 
DOPAMINE (DA) 
Dopaminergic fibres end in close proximity to GnRH projections in the perivascular 
region of the ME and synaptic contacts between these systems have been reported 
in the ME of the ewe and also in the medial POA of the rat (Ajika, 1980; Watanabe 
and Nakai, 1986; Kuljis and Advis, 1989). 
Evidence exists to support both an inhibitory and a stimulatory role for DA in GnRH 
release. This may be indirect since both Sarkar and Fink (1981) and Jarjour et al. 
(1986), using in vivo and in vitro systems in the rat, suggest that the DA-induced 
release of GnRH is most likely attributable to DA-induced release of NE. This is 
supported by the following observations: 1) an a.-adrenergic antagonist prevented the 
DA effect (in vitro); and 2) normal NE synthesis is required for the occurrence of a full 
GnRH surge (in vivo). Recently Contijoch et al. (1992) reported that DA decreases 
GnRH release from denervated ME tissues in hens. However, at the level of 
biosynthesis, Li and Pelletier (1992) demonstrated that GnRH mRNA levels in male 
rats are positively regulated by DA. 
The opposite effects of DA on GnRH biosynthesis and release are probably due to the 
existence of pharmacologically distinct DA receptors in the CNS. 
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SEROTONIN 
Kiss et al. (1985) using a combination of immunocytochemistry and autoradiography 
demonstrated that serotoninergic axons terminate on GnRH neurons in the POA of the 
rat. However, recent studies were unable to detect mRNA encoding for serotonin 2, 
1 A or 1 C receptor subtypes in GnRH neurons of both OVX and OVX-E2 treated rats 
(Wright and Jennes, 1993). 
Arias et al. (1990) using both in vivo and in vitro systems demonstrated that serotonin 
is involved in mediating GnRH release. Their results show age related opposite 
effects of serotonin on GnRH neurons in the female rat. Enhancement of GnRH 
release is observed at 14 days of age, while inhibition occurs in 30-day-old rats. They 
postulate that this switch in the changing effect of serotonin on Gn RH release in 
juvenile rats may be involved in the onset of puberty. 
Wright and Jennes (1993) have suggested that these effects are not mediated by 
direct activation of serotonin 2, 1A or 1 C receptors on GnRH neurons. Instead 
serotonin may act via, yet unidentified serotonin receptor subtypes or via non-
serotoninergic intermediary neurons. 
GLUTAMATE (GLU) 
GLU, aspartate and other excitatory amino acids are thought to act mainly as 
neurotransmitters at excitatory synapses in the vertebrate CNS. GLU has been found 
to activate ionotropic and/or metabotropic receptors in the CNS. GLU binding to 
ionotropic receptors results in Ca2+ entry through a channel within the receptor, as well 
as through voltage-sensitive Ca2+ channels (VSCC). N-methyl-D-aspartate (NMDA) 
is a selective agonist for one subtype of ionotropic receptor, the NMDA receptor, 
whereas a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and/or 
kainate is a selecitve agonist for the other subtype, the AMPA/kainate receptor. GLU 
binding to metabotropic receptors may result in stimulation of inositol 1,4,5-
triphosphate (IP3) production and release of Ca2+ from intracellular stores (Mayer and 
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Miller, 1990). Furthermore, recent evidence has demonstrated that the GnRH 
neuronal network receives synaptic input from GLU nerve fibers, providing concrete 
anatomical evidence for direct excitatory GLU control of GnRH release (Van den Pol 
et al., 1990; Jennes and Dupre, 1991; Goldsmith et al., 1994). 
Bourguignon et al. (1989a) provided the first direct physiological evidence that 
neuroexcitatory amino acids trigger the release of GnRH. In vitro incubation of 
hypothalami from 50-day-old male rats in the presence of increasing concentrations 
of kainate or NMDA resulted in a dose-related stimulation of GnRH release. At 
concentrations of 10, 50 and 100 mM, NMDA was about twice as potent as similar 
amounts of kainate in eliciting GnRH release. They concluded that the effects of 
kainate and NMDA are mediated through distinct receptor types, since the GnRH 
response to kainate was not affected by factors such as glycine or Mg
2
+ concentrations 
which did affect the response to NMDA. Studies using male rat arcuate nucleus-
median eminence (AN-ME) fragments in vitro have demonstrated that, at this level, 
GnRH release is mediated via non-NMDA receptors (Donoso et al., 1990; Lopez et 
al., 1992). In addition, Bourguignon et al. (1989b) found that MK-801, a non-
competitive NMDA antagonist, could suppress the pulsatile secretion of GnRH from 
hypothalamic explants. In contrast, pulsatile release of GnRH was not affected by the 
non-NMDA-receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX). 
Urbanski and Ojeda (1990) demonstrated that in prepubertal female rats the pulsatile 
administration of NMDA resulted in precocious activation of the reproductive system. 
Furthermore, a number of groups have shown that the administration of MK-801 
delayed the subsequent onset of puberty in female rats (Urbanski and Ojeda, 1990; 
MacDonald and Wilkinson, 1990; Veneroni et al., 1990; Meijs-Roelofs et al., 1991 ). 
In addition, the administration of NMDA to 16- and 30-day-old female rats enhanced 
GnRH content in the anterior POA and MBH. Estrogen and progesterone pretreatment 
potentiated this increase of GnRH induced by NMDA in the 16-day-old-rats, but not 
in the 30-day-old rats (Carbone et al., 1992). Similar studies by Bourguignon et al. 
(1990a) reported that the NMDA induced secretion of GnRH from hypothalamic 
explants of male rats required lower concentrations at 25 days than at 15 or 50 days 
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of age. Furthermore, this group have shown that NMDA inhibits the in vitro secretion 
of GnRH from hypothalami from immature male rats (Bourguignon et al., 1992a). 
Their data indicate that the NMDA receptors involved in the stimulatory control of 
pulsatile GnRH secretion are increasingly activated between 15 and 25 days in the 
male rat, a period preceding the onset of puberty (Bourguignon et al., 1990a). They 
conclude that a sequential reduction in activity of inhibitory and facilitatory NMDA 
receptors provides a developmental basis for the neuroendocrine mechanism of onset 
of puberty. Additional studies by Bourguignon et al. (1992b) have shown that the age-
related changes in NMDA receptor activation occur in the absence of gonads, 
questioning the role of T in this response. 
Furthermore, recent studies have reported that NMDA or kainate administration to rats 
rapidly increases GnRH mRNA levels in parallel with increases in GnRH release 
(Petersen et al., 1991; Liaw and Barraclough, 1993; Roberts and Gore, 1993). 
GAMMA-AMINOBUTYRIC ACID (GABA) 
GABA is an inhibitory neurotransmitter and is thought to exert its effect directly on 
GnRH cells since GABA-ergic neurons make synaptic connections with GnRH cell 
bodies in the medial POA of the rat (Leranth et al., 1985a). In addition, recent studies 
by Petersen et al. (1993) demonstrated the presence of GABAA receptor subunit 
mRNA in GnRH neurons in rat POA. 
Evidence from in vitro and in vivo studies indicate that GABA both stimulates and 
inhibits GnRH release from ME. It appears that these opposite effects of GABA on 
GnRH release may be a result of differential activation of two classes of receptors. 
Studies with adult female rats demonstrate that the GABAA receptor mediates the 
stimulatory effect and the GABA6 receptor the inhibitory effect (Masotto et al., 1989). 
The effect of GABAA on in vivo GnRH release may be mediated by NE, since 
depletion of endogenous NE resulted in a 17-fold reduction of GABAA induced GnRH 
release from rat ME (Luo et al., 1991 ). In addition, the inhibitory effect of GABA6 
receptors on GnRH cells may involve a presynaptic effect, whereby GABA tonically 
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inhibits those NE terminals which innervate GnRH neurons. This can be deduced 
from the fact that inhibition of GnRH release does not occur when presynaptic 
inhibition of NE release is absent (Nikolarakis et al., 1988; Masotto et al., 1989). 
In addition, studies by Donoso et al. (1992) demonstrated that a GABAA agonist 
increased GnRH and enhanced L-GLU induced GnRH release from AN-ME fragments 
in vitro. A GABAa agonist, on the other hand, reduced L-GLU induced GnRH release. 
These results provide evidence for a functional link between GABA-ergic and GLU-
ergic neurotransmission at the level of the AN-ME, an area known to be involved in 
the regulation of GnRH secretion. 
Furthermore, since GABA neurons contain estrogen receptors, changes in plasma E2 
could affect GnRH release by modulating activity in GABAergic neurons (Flugge et al., 
1986). 
Interestingly, studies by Moguilevsky et al. (1991) with female rats demonstrated that 
GABA exerts a stimulatory tone on gonadotropin secretion in prepubertal rats (16 days 
of age) and an inhibitory one in peripubertal animals (30 days old). This effect is most 
probably mediated by GABAA receptors. As suggested for the serotoninergic system, 
this change in effect which takes place during sexual maturation maybe related to the 
central mechanisms involved in the onset of puberty. This change could involve the 
development of a different subtype of this GABA receptor or, more likely, the 
maturation of interneuronal contacts of the GABAergic system with other 
neurotransmitter systems involved in the control of the GnRH-gonadotropin system 
(Olsen and Tobin, 1990; Moguilevsky et al., 1991 ). 
Bergen et al. (1991) demonstrated that activation of GABAa receptors in the POA of 
OVX rats resulted in inhibition of GnRH gene expression. It is not yet known whether 
this effect is due to a presynaptic effect (i.e. a decrease in excitatory tone to the GnRH 
cells) or whether GABAa receptors located on the GnRH cells mediate this effect 
directly. 
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HISTAMINE (HA) 
Studies by Miyake et al. (1987) have showed that HA, via H1 receptors, induced the 
in vitro release of GnRH from rat MBH. They suggest that the H1 receptors are 
involved in both the basal and E2-induced GnRH release. 
1.2.2 NEUROPEPTIDES 
ENDOGENOUS OPIOID PEPTIDES (EOP) 
Three major groups of EOP are known: the endorphins, enkephalins and dynorphins. 
These peptides are produced in separate neuronal systems and each group is found 
within the hypothalamus. Much of the evidence suggests that EOP may be an integral 
component of the neural circuitry which exerts an inhibitory control on GnRH release 
from the ME. Previously a large body of evidence suggested that EOP may exert their 
effects on GnRH secretion indirectly via modulation of NE release, however, more 
recent work has focused on both the independent effects, as well as the interaction 
of these two systems (Kalra and Kalra, 1983; Bicknell, 1985). 
There are at least two sites where opioids may affect GnRH neurons, i.e. in the vicinity 
of the cell bodies and in the region containing their nerve terminals. Chen et al. 
(1989b) demonstrated that ~-endorphin-containing neurons constitute almost 10% of 
the synaptic input to GnRH neurons in the DBB/POA of the male rat. Similarly, Thind 
and Goldsmith (1988) reported the presence of symmetrical synapses between opioid 
and GnRH neurons at the infundibular lip (IL) in juvenile rhesus monkeys. The IL is 
situated just below the AN and it is suggested that these opioid neurons directly inhibit 
the nearby GnRH pulse generator. Although these data provide anatomical evidence 
in support of a direct modulation of GnRH release by opiates they do not, however, 
rule out a possible intermediary effect of opiates on other neuronal systems known to 
be involved in the control of GnRH release. 
Morphine, an opiate agonist, inhibits GnRH release from rat and human MBH in vitro. 
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The suppression of pulsatile GnRH release induced by morphine in human MBH was 
reversed by the opiate µ-receptor antagonist, naloxone (NAL) (Rotsztejn et al., 1978; 
Rasmussen et al., 1990). NAL can also stimulate the in vitro release of GnRH from 
POA-MBH fragments of both intact and castrated rats (Kalra et al., 1987). In addition, 
in vivo studies showed that NAL induced GnRH release (by increasing GnRH pulse 
amplitude) and was equally effective in both intact and OVX rats (Karahalios and 
Levine, 1988). 
The interaction between opioid and noradrenergic systems on GnRH release by POA-
MBH explants from intact postpubertal female rats was investigated by Clough et al. 
(1990). Their results demonstrate a potentiating interaction between opioid antagonism 
and a-adrenergic stimulation on the release of GnRH in vitro. This suggests that 
separate mechanisms of GnRH control by each class of neurotransmitter is present. 
Studies involving the electrical activity of the GnRH pulse generator by Nishihara et 
al. (1991 ), lead them to suggest that the noradrenergic and opioid peptidergic systems 
have tonic facilitatory and inhibitory influences, respectively, on GnRH pulse generator 
activity in OVX rats. Neither of these neuronal systems themselves appear to be the 
pulse generator, but both appear to be modulators of the pulse generator. In contrast, 
in vitro studies with hypothalami from adult and prepubertal male rats found that the 
ability of NAL to release GnRH was inhibited by an a1-antagonist, suggesting that the 
µ-receptor-mediated opioid inhibition of GnRH secretion involves an intermediary CA 
mechanism (Leposavic et al., 1991 ). To date it remains unclear where the opioid and 
noradrenergic systems interact in the regulation of GnRH release. 
Furthermore, the opioid neurons, analogous to CA neurons, concentrate steroids and 
are thus implicated in mediating the effects of gonadal steroids on GnRH secretion 
(Bicknell, 1985). 
Hahn and Fishman (1985) have suggested that changes in the number of brain opiate 
receptors may be involved in gonadal steroid modulation of the sensitivity of the GnRH 
pulse generator to EOP. In addition, whereas EOP tonically inhibits GnRH release in 
adult male rats it fails to do so in immature animals. However, hypothalamic 
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fragments obtained from immature male rats treated in vivo with T were capable of 
responding to NAL with GnRH release in vitro. This data suggests that in the rat the 
maturation of the EOP system is a component of male puberty that is induced by the 
peripubertal T rise (Nazian, 1992). 
NEUROPEPTIDE Y (NPY) 
Several studies have demonstrated that NPY, a 36 amino acid peptide, is involved in 
the control of GnRH release. NPY may act directly on GnRH neurons since synaptic 
contacts between NPY and GnRH neurons have been found in the sheep and rat POA 
(Norgren and Lehman, 1989; Tsuruo et al., 1990). Alternatively, since NPY and NE 
co-exist in certain neurons, NPY may act either co-operatively or via the adrenergic 
pathways to stimulate GnRH release (Everitt et al., 1984; Allen et al., 1987). 
Exposure to 1 µM NPY stimulated the in vitro release of GnRH from MBH fragments 
obtained from steroid-replaced OVX rats, but not from hormonally untreated OVX rats 
(Crowley and Kalra, 1987; Sabatino et al., 1989). Similarly, in vitro perfusion 
experiments indicated that isolated hypothalami from intact, but not OVX rabbits, 
responded to NPY with an increase in GnRH release (Khorram et al., 1988). 
Furthermore, the same group reported that NPY has a bimodal effect on MBH release 
of GnRH in PP perfusates, producing a stimulation of GnRH release in intact rabbits 
while inhibiting its release in OVX rabbits (Khorram et al., 1987). These results 
suggest that NPY is a steroid-dependent modulator of GnRH release in rats and 
rabbits. In support of this, studies by Sar et al. (1990) have shown the co-localization 
of NPY and E2 in the hypothalamus of the rat. In contrast, the presence of steroid 
hormones is not required for the stimulatory action of NPY on GnRH release in non-
human primates. This is supported by experiments by Woller and Terasawa (1991) 
who found that the direct infusion of NPY into the stalk-median eminence (S-ME) 
increased GnRH release in both gonadectomized male and female rhesus monkeys. 
Further studies by Woller et al. (1992) using the same experimental system lead them 
to conclude that NPY is an important component of the GnRH pulse generating 
system since: 1) NPY release in the S-ME was pulsatile, 2) NPY pulses occur 
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synchronously with GnRH and LH pulses, and 3) immunoneutralization of endogenous 
NPY into the S-ME suppressed pulsatile GnRH release. 
The infusion of prazosin, an a.1-antagonist, into the MBH of OVX E2-treated rabbits 
blocked the expected NPY-induced GnRH release. These results by Berria et al. 
(1991) suggest that NPY-stimulated MBH-GnRH release is mediated by or dependent 
upon a.1-adrenergic pathways. In addition, Sahu et al. (1990) found that NAL evoked 
a concurrent release of both NPY and GnRH from MBH of E2-primed rats. This finding 
lead them to propose that a decreased inhibitory opioid tone results in an increase in 
both NPY and NE release with the subsequent enhancement of GnRH release. 
Sutton et al. (1988) observed that, after birth, the content of NPY increases in parallel 
with that of GnRH in the hypothalamus and POA until stabilizing around puberty. 
Furthermore, the preovulatory GnRH surge is accompanied by a surge of NPY in the 
pubertal female rat. The same group examined the effects of centrally administered 
anti-NPY in pubertal female rats. Anti-NPY reduced the magnitude of both the 
proestrous -GnRH and -LH surges. Together these findings suggest that NPY plays 
a facilitatory role in the initiation of the GnRH surge that leads to the onset of puberty 
(Minami et al., 1990). 
GALANIN (GAL) 
Merchenthaler et al. (1990) reported that GAL neurons appear to directly innervate 
GnRH neurons in the rat. Furthermore, they noted GAL is co-localized in a subset of 
GnRH neurons in the POA. These studies support the idea that GAL may play a role 
in regulating GnRH secretion. 
Merchenthaler (1991) also reported the following results concerning the differential co-
expression of GAL and GnRH in the rat brain: 1) the number of neurons containing 
both peptides in females, regardless of the stage of the estrous cycle, is 3-4 fold 
higher than in males; 2) ovariectomy results in a decline in the number of neurons co-
expressing GAL and GnRH to levels similar to those seen in the male; 3) E2 or T 
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replacement of adult gonadectomized animals enhances co-expression in female but 
not male animals. The sexual dimorphism and the estrogen-dependent co-expression 
of GAL indicates the importance of E2 in the regulation of the co-expression of GAL 
in a subpopulation of GnRH neurons. 
In addition, Lopez and Negro-Vilar (1990) showed that GAL stimulated the in vitro 
release of GnRH from male rat AN-ME fragments. This effect appears to involve the 
activation of a 1-adrenergic receptors since prazosin, an a 1-antagonist, completely 
blocked the effect of GAL on GnRH release. 
CORTICOTROPIN-RELEASING HORMONE (CRH) 
A role for CRH, a 41 amino acid peptide, has been implicated in the mechanism by 
which stress inhibits the reproductive axis. Direct synaptic contacts between CRH and 
GnRH containing neurons have been demonstrated in the POA of the rat (MacLusky 
et al., 1988; Csiffary et al., 1990). 
In vivo results have shown that CRH inhibits the release of GnRH into the 
hypophyseal portal circulation in female rats (Petraglia et al., 1987). In support of this 
observation in vitro evidence has demonstrated that CRH inhibits GnRH release from 
rat hypothalami (Nikolarakis et al., 1986; Gambacciani et al., 1986). Further 
experiments by the same group demonstrated that in vitro treatment of hypothalamic 
slices from male rats with the CRH receptor antagonist, CRF9-41 (1 µM), resulted in 
a significant increase in GnRH release. Comparable results were obtained in vivo 
during push-pull perfusion of the AN-ME region with CRF9-41 (Nikolarakis et al., 
1988). In addition, CRH suppressed the pulsatile release of GnRH from macaque 
MBH in vitro and decreased the in vivo GnRH pulse generator activity in OVX rhesus 
monkeys (Williams et al., 1990; Mershon et al., 1991). 
GONADOTROPIN-RELEASING HORMONE (GnRH) 
Demonstration of GnRH nerve endings in synaptic contact with medial preoptic GnRH-
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containing perikarya provides morphological evidence to support the hypothesis that 
an intrinsic GnRH network is present (Leranth et al., 1985b; Pelletier, 1987). 
In vitro experiments using GnRH agonists have shown that GnRH inhibits its own 
release from rat MBH. The agonists suppressed both basal and K+-stimulated GnRH 
release (DePaolo et al., 1987; Zanisi et al., 1987). Studies with rat hypothalami by 
Bourguignon et al. (1987) demonstrated that the frequency of GnRH secretory pulses 
in vitro is reduced in the presence of GnRH agonists. In addition, Valenca et al. 
(1987) observed that a GnRH antagonist enhances GnRH secretion from rat ME 
fragments in vitro in a concentration-dependent manner. Moreover, in vivo studies by 
Sarkar (1987) showed that administration of a GnRH agonist into the third venticle of 
OVX rats decreased both the amplitude and the frequency of endogenous GnRH 
pulses in portal blood and this effect was prevented by the simultaneous administration 
of a GnRH antagonist. 
Together the above data support the existence of a negative ultrashort feedback 
mechanism for GnRH at the level of the hypothalamus. 
OTHER PEPTIDES 
NEUROTENSIN (NT): As GnRH neurons within the preoptic periventricular area of 
the male mouse are contacted by NT axons and a sub-population of rat GnRH 
neurons express NT receptors, NT is believed to affect GnRH secretion directly 
(Hoffman, 1985; Beaudet et al., 1993). Recent experiments demonstrated that 
infusion of NT into the S-ME of OVX rhesus monkeys stimulated GnRH release (Pu 
and Terasawa, 1993). Furthermore, Herbison and Theodosis (1992) have shown that 
in the rat POA NT neurons possess estrogen receptors, and may therefore be involved 
in mediating the effects of gonadal steroids on GnRH biosynthesis and release. 
ANGIOTENSIN II (ANG II): Steele et al. (1992) demonstrated that, in E2 and 
progesterone-treated OVX rats, intracerebroventricular infusion of ANG II stimulates 
GnRH release from the ME. 
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VASOPRESSIN (VP): Thind et al. (1991) provided evidence that VP-immunoreactive 
(ir) boutons formed symmetrical synapses with GnRH-ir cell bodies in the supraoptic 
nucleus of cynomolgus monkeys. Whether VP itself and/or co-existent neuroeffectors 
act directly on GnRH secretion remains to be determined. 
SUBSTANCE P (SP): Tsuruo et al. (1991) found that in the septo-preoptic area SP 
neurons make synaptic contact with GnRH-containing perikarya and dendritic 
processes in the rat. SP has also been reported to stimulate GnRH release from rat 
MBH in vitro (Ohtsuka et al., 1987). 
NEUROPEPTIDE K (NPK): Sahu and Kalra (1992) observed that NPK acting via NK-
2 receptors suppressed both the basal and KCl-induced GnRH release from female 
rat AN-ME in vitro. 
PROLACTIN (PRL): Azad et al. (1990) showed that in vitro immunoneutralization of 
hypothalamic PRL significantly decreased the release of GnRH from male rat 
hypothalami, suggesting that hypothalamic PRL has a stimulatory effect on GnRH 
release. 
DEL TA-SLEEP-INDUCING PEPTIDE (DSIP): Vallet et al. (1990) demonstrated that 
DSIP and GnRH are co-localized in the same neurosecretory vesicles in the rat ME. 
This result implies that these peptides are co-secreted. 
1.2.3 STEROIDS 
It is clear that the interplay between the multiple neuronal systems modulating the 
activity of GnRH synthesizing and releasing neurons is complex and subject to 
regulation by gonadal steroids. Aside from modifying the rhythmic GnRH release by 
modulating other systems affecting GnRH neurons, gonadal steroids may directly 
influence the activity of the GnRH neurons through feedback mechanisms exerted at 
hypothalamic and/or pituitary level (Zanisi and Messi, 1991 ). 
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Recently, a number of in vivo and in vitro studies have demonstrated that steroid 
hormones can affect GnRH biosynthesis and release. The use of different model 
systems by various groups has lead to conflicting results, most of which are contrary 
to the assumption that gonadal steroids act in the CNS to restrain GnRH secretion (for 
review see Kalra and Kalra, 1989). The ensuing discussion is a brief overview of the 
more substantiated work conducted to date in male and female rats. 
Numerous studies in the male rat have shown that castration leads to a decrease in 
the MBH GnRH content and a gradual decrease in the amounts of GnRH in nerve 
terminals in the ME, while in the POA the levels remain unchanged (Chen et al., 1977; 
Gross, 1980; Bourguignon et al., 1984). Ramirez et al. (1991) have suggested that 
castration does not lead to changes in frequency of the GnRH pulse generator, but 
that the main control of the testis is either by regulating the amount GnRH discharge 
in response to an action potential and/or in regulating the number of active GnRH 
neurons. In contrast, recent work by Phelps et al. (1992) found that at multiple days 
after castration that there was no consistent change detected in the overall amount, 
pulse amplitude or frequency of the GnRH signal reaching the pituitary. At the level 
of GnRH biosynthesis, neuronal GnRH mRNA levels are either increased (Toranzo et 
al., 1989), unchanged (Wiemann et al., 1990; Malik et al., 1991) or even decreased 
(Rothfeld et al., 1987; Park et al., 1988) following castration. In addition, contrary to 
expectation, the suppression of hypothalamic GnRH release or levels in vitro or in vivo 
has not been observed after T treatment in castrated rats. More surprisingly, when 
T replacement is initiated immediately after castration, it readily prevents the 
castration-induced fall in the MBH GnRH levels and release both in vivo and in vitro 
and release in response to a number of secretagogues. However, this example of T 
replacement is no longer effective if a longer interval (> 1-2 weeks) is allowed to elapse 
after castration (Kalra and Kalra, 1989). 
As in male rats, gonadal ablation in female rats eventually leads to a decrease in 
hypothalamic GnRH output in association with the fall in hypothalamic GnRH content 
(Kalra, 1976). Furthermore, ovariectomy results either in unchanged (Kelly et al., 
1989) or reduced GnRH mRNA levels (Roberts et al., 1989; Kim et al., 1989; Park et 
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al., 1990). There is also considerable agreement that E2 treatment in OVX rats 
increases GnRH output and that progesterone can release GnRH in vitro only from 
hypothalami primed with estrogen (Kim and Ramirez, 1982; Drouva et al., 1985; Kalra 
and Kalra., 1989). As well as stimulating the release of GnRH, E2 and progesterone 
also increase the levels of GnRH mRNA (Kim et al., 1989; Rosie et al., 1990). In 
addition, it is becoming more evident that in vivo output of the GnRH pulse generator 
can be differently controlled by estrogen and progesterone. For instance, estrogen 
appears to increase the frequency of the signal, whereas progesterone predominantly 
changes the amplitude of the GnRH signal (Ramirez eta!., 1985; Dluzen and Ramirez, 
1986). Progesterone administered systemically or in short pulses directly into the 
hypothalamus can trigger remarkable changes in the amplitude of the GnRH signal 
without measurable changes in frequency (Ramirez et al., 1985). 
Recently morphological evidence has shown that GnRH-ir terminals provide synaptic 
input to estrogen receptor-ir cells in a restricted part of the medial POA in the female 
guinea pig. Since GnRH-ir cells are thought to be regulated by estrogen responsive 
neurons, these results potentially identify an anatomical substrate for a regulatory 
feedback circuit between these two systems (Langub et al., 1991 ). 
Although gonadal steroids exert a negative effect on gonadotropin release from the 
pituitary, it seems that in general, steroids have a positive effect on GnRH biosynthesis 
and release in most model systems investigated. In summary: 1) in the absence of 
gonads the neurosecretory activity of GnRH neurons is markedly diminished; 2) 
steroids increase GnRH secretion in gonadectomized rats. These results have lead 
to the proposal that T, E2 and progesterone, either on their own or together with other 
steroidal or non-steroidal secretions of the gonads, may in fact augment the rate of 
GnRH neurosecretion (Kalra and Kalra, 1989). 
Clearly, further studies are necessary to provide a unified view on the exchange of 
information between the gonads and hypothalamus for control of reproduction. 
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1.3 CONCLUSION 
This review has considered the potential role(s) of various neuroendocrine factors in 
the physiological regulation of pulsatile GnRH/LH release. In summary, the GnRH 
neurosecretory system appears to be regulated at many levels, and by a variety of 
neural and endocrine factors with a complex interplay amongst stimulatory and 
inhibitory systems (see Table 1 ). 
The various effects observed on GnRH release by the same neurotransmitters and 
neuropeptides are possibly due to different experimental conditions i.e. age, sex, 
species and the endocrine status of the animal. Interestingly, the latter may play an 
important role in the regulation of hypothalamic neuropeptide receptors. The up and/or 
down regulation of receptor densities may be part of the mechanisms mediating the 
effects of gonadal steroids. 
Also, the different effects of various hormones on the hypothalamic activity of some 
neural systems i.e. DA, Serotonin and GABA during sexual maturation have been 
observed. It has been proposed that sexual maturation and the onset of puberty 
involve qualitative changes in the effect of sexual hormones on the neural systems 
regulating GnRH release (Carbone et al., 1992). These effects may include the 
maturation of different receptor subtypes and/or the formation of new interneuronal 
contacts involved in the control of GnRH. 
What are the reasons for such an intricate system? The GnRH neurosecretory system 
is required to perform a variety of biological tasks. First and foremost, the GnRH 
neuronal population is charged with the responsibility of maintaining basal activity 
within the hypothalamic-hypophyseal-gonadal axis. The GnRH neuron is also called 
on to execute major shifts in the activity of the axis- from dormancy to activity and 
back to dormancy, and perhaps in some cases from one of these states to some 
physiological shade of gray in between. Puberty and seasonality are, of course, two 
examples of situations in which such shifts occur. 
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Table 1: Summary of neural systems involved in GnRH biosynthesis and release. 
Anatomical Stimulates Inter- Onset Co-
evidence (+) and/or action of local-
Inhibits(-) with .. puberty ized 
NE: a1 Apposition + See ? 
below 
DA Synaptic 
+/- NE contact 
Serotonin II ? 
+/-
GLU Apposition + GABA Yes 
GABA:A Synaptic NE/GLU ? 
+/-
B contact 
-
NE/GLU 
HA: H1 + 
EOP Synaptic NE/NPY ? 
-contact 
NPY II NE/EOP Yes + 
GAL II + NE Yes 
CRH II 
-
GnRH II Yes 
-
NT Synaptic + 
contact 
ANG II + 
VP Synaptic ? 
contact 
SP II + 
NPK: NK-2 
-
PRL + 
DSIP ? Yes 
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In primates, the neural mechanism that governs pulsatile release of GnRH, the so-
called GnRH pulse generator, is held in a state of "suspended animation" during the 
greater part of prepubertal development. This mechanism requires a very efficient 
regulatory process. Furthermore, the GnRH neurosecretory system is required to 
produce an abrupt signal for the initiation of the LH surge and must also be able to 
respond to acute (stress) and chronic (prolonged reduction of circulating gonadal 
hormones) perturbations. 
Since all endocrine and neural systems in vertebrates have evolved to a degree of 
great complexity, it is not surprising that neuroendocrine cells which are at the 
interface of these two systems should be regulated by a plethora of neural, endocrine 
and other factors. To identify the mechanisms underlying the GnRH pulse generator, 
the current study focuses on the in vitro autoregulation of GnRH using an immortalized 
GnRH secreting cell-line. 
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2: DEVELOPMENT OF PROTOCOLS FOR GnRH mRNA 
DETECTION AND ANALYSIS OF MODULATED GnRH 
RELEASE USING A GT1-7 CELL CULTURE SYSTEM 
2.1 INTRODUCTION 
The scarcity and the diffuse anatomical distribution of GnRH- containing neurons in 
the forebrain has precluded extensive characterization of their cell biology (Silverman, 
1988). Thus, the activation of GnRH neurons, while implied by increased GnRH 
output, remains a matter of hypothesis and conjecture, largely due to the absence of 
an experimental technique for measuring the activity of individual GnRH neurons. To 
obtain significant numbers of GnRH neurons for experimental purposes, Mellon et al. 
(1990) recently developed an immortalized hypothalamic GnRH-secreting cell line. 
Briefly, these investigators constructed a hybrid gene that contained 2 kb of the rat 
GnRH promoter coupled to the coding region for the large T-antigen of simian virus 
(SV)-40. This construct was introduced into transgenic mice, and some of the 
offspring developed anterior hypothalamic tumours. These tumours were then used 
for the development of clonal, differentiated, neurosecretory cell lines (GT1-1, GT1-3 
and GT1-7). These cells are phenotypically and immunologically neuronal, secrete 
GnRH and express its mRNA (Mellon et al., 1990). As depicted in Figure 1, cultured 
GT1-7 cells exhibit the classical neuronal appearance of GnRH neurons. In addition, 
Liposits et al. (1991) have shown that these cells establish numerous interconnections. 
Neighbouring neurons are coupled by tight junctions, while more distant cells are 
interconnected with neuronal axon-like processes and collaterals. This cellular 
organization could serve to coordinate GnRH secretion from individual neurons. In 
support of this concept of synchronized release, studies by Martinez de la Escalera 
et al. (1992a) and Wetsel et al. (1992) have shown that these cells maintain the 
pulsatile pattern of GnRH secretion that is critical for successful reproduction. 
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The concentration of GnRH which reaches the anterior pituitary via the hypothalamo-
hypophyseal portal system appears to be controlled in part by the rate of GnRH 
degradation within the hypothalamus and/or pituitary (Griffiths et al., 1975; Lasdun et 
al., 1989). The metalloendopeptidase EC 3.4.24.15 (EP 24.15), which cleaves the 
Tyr5-Gly6 bond of GnRH is the primary degrading enzyme in pituitary and hypothalamic 
membrane preparations (Griffiths eta/., 1975; Lasdun eta/., 1989). In addition, GT1-7 
cells were found to secrete EP 24.15 (M.J. Glucksman, personal communication). 
This section describes the development of experimental protocols for GnRH mRNA 
detection, followed by methodology for the establishment of the GT1-7 cell culture 
system for the analysis of secretagogue-induced GnRH release. EP 24.15 by 
modifying endogenous GnRH levels could interfere with investigations into the e_ffects 
of exogenous factors on GnRH release. Thus, the absence of EP 24.15 (or any other 
GnRH-degrading enzymes) in the proposed experimental system was determined prior 
to the initiation of the aforementioned studies. Results using the developed cell culture 
system showed the presence of GnRH mRNA as well as spontaneous GnRH release. 
Furthermore, this release was augmented by the addition of K+, L-GLU, forskolin and 
phorbyl-12-myristate-13-acetate (PMA). Lastly, K·- and forskolin-induced GnRH 
re lease was shown to be dependent on extracellular Ca2•• 
Figure 1: Phase-_contrast micrograph of a representive GT1-7 cell in culture. Note the 
distinct neuronal appearance, including neurite formation; Magnification: 
450x (a gift from Dr. N.llling). 
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2.2 MATERIALS AND METHODS 
2.2.1 CHEMICALS AND BUFFERS 
Reagents 
Activated charcoal, a-chymotrypsin, PMA and forskolin (dissolved in ethanol) (Sigma, 
St. Louis, MO); Dextran T70 (Pharmacia, Uppsala, Sweden). All other reagents were 
obtained from commercial sources and were of the highest purity available. 
Composition of buffers 
Phosphate buffered saline (PBS) (1 Ox) for cell culture was 1.5 M NaCl, 0.03 M KCI, 
0.1 M N~HP04 , 0.02 M KH2P04 , pH 7.4. 
Buffer I con.sisted of 140 mM NaCl, 4 mM KCI, 1 mM MgCl2 , 1 mM CaCl2 , 8.3 mM 0-
glucose, 20 mM Hepes (pH 7.4), 6 mg/I phenol red, and 0.1 % (w/v) Bovine serum 
albumin (BSA) (fatty acid free, Pentax fraction V, Miles Laboratories, Elkhardt, IN). 
For 60 mM K+ stimulations the NaCl concentration was adjusted to 80 mM to maintain 
isotonicity of the buffer. 
PBS-gelatin buffer for radioimmunoassay (RIA) was 0.04 M NaH2P04.2H20, 0.15 M 
NaCl, 0.01 M disodium ethylenediaminetetra acetic acid (EDTA), 0.1 % (w/v) NaN3, pH 
7.0, with 0.1% gelatin (w/v), 0.1% (v/v) Triton X-100 (BDH Chemicals Ltd., Poole, UK). 
Lysis buffer for total cellular RNA extraction consisted of 4 M guanidinium thiocyanate 
(GuSCN), 0.025 M sodium citrate (pH 7.0), 0.5% (w/v) N-Lauroylsarcosine, 0.1 M ~-
mercaptoethanol. 
Diethyl pyrocarbonate (DEPC)-H20 for use in RNA extraction was prepared as 
follows: 300 µI DEPC (BDH Chemicals Ltd., Poole, U.K) was added to 500 ml distilled 
water (dH20), mixed and incubated at 37°C for at least 12 h and then autoclaved for 
40 min. 
Hybridization solution used for ribonuclease (RNase) protection assay consisted of 
4 M GuSCN, 0.1 M EDTA, 30 mM NaCl, 3 mM sodium citrate (pH 7.0), 0.02% (v/v) 
DEPC. 
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RNase solution used in RNase protection assay was 1 O mM Tris-HCI (pH 8.0), 300 
mM NaCl, 5 mM EDTA, 40 µg/ml RNase A and 2 µg/ml RNase T1 (Sigma, St. Louis, 
MO) 
Gel-loading buffer used for electrophoresis was 95% (v/v) formamide, 20 mM EDTA, 
0.05% bromophenol b!ue, 0.05% xylene cyanol. 
Tris-Borate buffer (TBE) for gel electrophoresis was 0.89 M Tris-HCI (pH 8.3), 0.89 
M Boric acid, 0.02 M EDTA. 
PIPES (piperazine-N-N'-bis [2-ethane sulfonic acid]) buffer used for Northern blot 
analysis consisted of 50 mM PIPES , 100 mM NaCl, 50 mM sodium phosphate, 1 mM 
EDTA and containing 5% sodium dodecyl sulphate (SOS). 
1 x SSC used for Northern blot analysis was 0.15 M NaCl with 15 mM sodium citrate 
(pH 7.0) 
2.2.2 PEPTIDES AND ANT/SERA 
GnRH pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-GlyNH2 
(R.C. del. Milton, University of Cape Town, Cape Town, 
South Africa) 
Antiserum 1076, was provided by Dr. R.P. Millar (MAC Regulatory Peptides Research 
Unit, University of Cape Town (UCT) Medical School, Cape Town, South Africa). This 
antiserum requires the region Trp3 to Pro9 for effective binding, and therefore 
recognizes both precursor and processed GnRH, as well as certain fragments of 
GnRH (King and Millar, 1982). Antiserum 678, was kindly provided by Dr. J.A. King 
(University of Cape Town, Cape Town, South Africa). This antiserum recognizes the 
N and C termini of GnRH and therefore detects only processed GnRH decapeptide 
(Dr.J.A.King, personal communication). 
2.2.3 CELL CULTURE 
Preparation of GT1-7 monolayered networks was a modification of the method as 
described by Mellon et al. (1990). Briefly, GT1-7 cells supplied by P.L. Mellon 
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(Regulatory Biology Laboratory, Salk Institute, La Jolla, CA) were maintained in 175 
cm2 tissue culture flasks (Nunc, Copenhagen, Denmark) at 37°C in a humidified 
atmosphere of 5% C02"95% air in Dulbecco's Modified Eagle's Medium (DMEM) with 
1 mg/ml D-glucose, 100 U/ml penicillin, 100 µg/ml streptomycin (Gibco, Grand Island, 
NY) and 10% (v/v) fetal bovine serum (FBS) (Delta bioproducts, South Africa). 
For experimental purposes cells were dislodged from confluent flasks using 0.02% 
EDTA in 1 x PBS and dispersed in medium using a Pasteur pipette. The suspension 
was centrifuged at room temperature for 1 O min at 800 x g and the pellet was 
resuspended in medium. An aliquot was taken for cell counting (1.5 x 107 cells/flask) 
and assesment of viability using the trypan blue exclusion technique (90%). Dispersed 
cells were resuspended in culture medium to give 2 ml/well for plating at a density of 
3 to 4 x 105 cells/well in 6-well plastic culture plates (Nunc, Copenhagen, Denmark). 
After 3 days in culture the cells formed a monolayered network in which each neuron 
made multiple interconnections with neighbouring cells (Figure 1 ). At this stage the 
medium was replaced with serum-free medium and incubated for a further 18 h. 
2.2.4 CULTURE STUDIES 
The following protocol was adhered to for experiments conducted in GT1-7 cells, any 
modifications within experiments are stated. 
After 18 h in serum-free medium the cells were washed twice for 1 O min in buffer I 
(1 ml/well) on a rotary shaker (60 rpm) at 37°C without CO2• The cells were 
stimulated for 15 or 30 min in 1 ml buffer I with or without secretagogues at 37°C (as 
for washes). After stimulation, the medium was collected in glass tubes and 
centrifuged at 4°C for 1 O min at 800 x g to remove detached cells. The supernatants 
were stored in vials at -20°C prior to RIA for secreted precursor and processed GnRH. 
For the determination of total protein content the cells were lysed with 1 ml/well 1 % 
(v/v) Triton X-100. To determine the effect of extracellular Ca2+ on GnRH release, 
GT1-7 cells were stimulated in buffer I with or without 1 mM CaCl2 for 15 min. 
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2.2.5 PROTEIN DETERMINATION 
In order to determine whether cell numbers between wells varied, the total protein 
content of each well was measured using the Bio-Rad protein assay system (Bio-Rad, 
Munich, Germany). Briefly, a standard curve was prepared using BSA as the standard 
(0 to 40 µg/ml in 2 ml dH20). The samples were diluted 1 :40 in 2ml dH20. 0.5 ml dye 
reagent concentrate was added to the standards and diluted samples and mixed by 
vortexing. After a period of 5 to 30 min the absorbance at 595 nm was measured 
using a spectrophotmeter (UV-160A, Shimadzu, Japan). The intra-assay well to well 
coefficient of variation was 4.3%. 
2.2.6 RIA OF GnRH 
The method of RIA used was a modification of that described by Hendricks et al., 
1975). 
Iodination and purification of GnRH 
Synthetic GnRH was labelled with 1251 (Amersham, England) and purified by high-
performance liquid chromatography (HPLC). Reagents were added to the iodination 
vial in the following order: 5 µg GnRH in 40 µI 0.5 M (NaH2P04) (pH 7.6); 1 O µI 1251 
(1 mCi); 1 O µI chloramine T (BDH Chemicals Ltd., Poole, U.K)(12 mg/5 ml 0.5 M 
NaH2P04 (pH 7.6)), mixed and the reaction was stopped after 1 O sec by the addition 
of 20 µI sodium metabisulphate (N~S20 5)(Calbiochem, La Jolla, CA) (4 mg/5 ml 0.5 
M NaH2P04 (pH 7.6)). The iodination mixture was applied to a Vydac C-18 reverse 
phase column (0.46 x 25 cm; 5 µm particle size; The Separations Group, Hesperia, 
CA) equilibrated with 0.01 M ammonium acetate (NH4Ac) (pH 4.6). Forty 1.5 ml 
fractions were eluted from the column with a flow rate of 1.5 ml/min using a gradient 
of Oto 60% acetonitrile (CH3CN) in 0.01 M NH4Ac (pH 4.6) over 40 min. 
The radioactivity of each fraction was determined in an autogamma spectrometer 
(Riastar, Packard Instruments). Two well-separated peaks of radioactivity were 
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yielded (Figure 2). The first peak represented unreacted iodide, and the second peak 
1251-GnRH. Fractions containing the 1251-GnRH were pooled, aliquoted into vials (4 x 
106 cpm/vial), and stored at -20°C. 1.5 ~------------~ 
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~ 
Figure 2: Iodination of mGnRH. P.. u 
The first peak shows 
unreacted iodide and 
the second 1251-GnRH. 
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FRACTION NUMBER 
100 µI standard (GnRH) serially diluted in PBS-gelatin buffer, or sample, 200 µI PBS-
gelatin buffer and 100 µI of antiserum 1076 (1:10 000 initial dilution) and 100 µI 1251-
GnRH (1 O 000 cpm) were incubated in glass tubes overnight at 4°C. Non-specific 
binding (NSB) was assessed by incubation of 100 µI 1251-GnRH with 400 µI PBS-
gelatin buffer. Separation of antibody-bound and free 1251-GnRH was achieved by the 
addition of a donkey anti-rabbit y-globulin serum (Sac-Cel, IDS, Washington, England; 
100 µI of a 1 :2 solution in PBS-gelatin buffer). Tubes were incubated at room 
temperature for 30 min, 1 ml dH20 added and centrifuged at 4°C for 15 min at 2000 
x g. The supernatants were decanted and the pellets counted for 1 min in an 
autogamma spectrometer. The assay sensitivity (96% of total binding) was 1.2 
pg/tube, with 50% inhibition of total binding occuring at 15.7 pg. The intra-assay 
coefficient of variation was 4.1 %. Each sample from an experiment was measured in 
duplicate in a single assay. All test compounds used in the experimental system were 
examined for possible interference in the RIA. None of the compounds displayed any 
significant interference in the assay system. 
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2.2. 7 DEGRADATION STUDIES 
To investigate the presence of GnRH-degrading enzymes within the experimental 
system, the following approach was employed. Firstly, in order to achieve optimal 
binding of processed GnRH decapeptide, an assay system was developed using 1251-
GnRH and antiserum 678. This involved titration of antiserum 678 (1: 50 to 51200 
final dilution) in the presence of a constant amount of 1251-GnRH (iodination procedure 
as in 2.2.6). As shown in Figure 3 maximal binding (85-89% of total counts (TC)) of 
labeled peptide was achieved by incubation at 4°C for 18 h, followed by separation of 
antibody-bound from free 1251-GnRH. This required the addition of a 0.5 ml charcoal 
(0.5% w/v)-dextran (0.05% w/v) mixture, incubating at 4°C for 1 O min, followed by 
centrifugation at 4°C for 15 min at 2000 x g. Thereafter, supernatants were poured 
over and counted in an autogamma spectrometer(*). Secondly, maximal binding of 
1251-GnRH in the presence of 2 ng/ml GnRH (estimated concentration within 
experimental system) was assessed. As shown in Table 2, a final dilution of 1: 50 
(antiserum 678) was sufficient to achieve maximal binding of 1251-GnRH in the 
presence of 2 ng/m I G n RH. 1 o o .--.---,,----,--,.--.----,-~-,----.---.---.--,---.--, 
80 
........... ~ .. 
" 
60 
% TC 
40 
20 
NSB 1:50 200 800 3200 12800 51200 
Antiserum 678 dilutions 
Figure 3: Titration of antiserum 678 in the presence of constant 1251-GnRH. 
Increasing dilutions of antiserum 678 were incubated in the presence of 
constant 1251-GnRH at 4°C for 18 h. NSB (3-4%). Separation of antibody-
bound from free 1251-GnRH was achieved as described in the text (2.2.6). 
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Table 2: % Binding of 1251-GnRH to antiserum 678 
in the presence of 2 ng/ml GnRH. 
%TC 
NSB 3.2 
1 :50 678 86.5 
1 :50 678 
+ 2ng/ml GnRH 86.0 
Following the completion of the initial studies, degradation of 1251-GnRH by GT1-7 cells 
was investigated. Pancreatic a-chymotrypsin, known to cleave the Tyr-Gly6 and Trp3-
Ser4 bonds of GnRH, served as the +ve control (Schally et al., 1971 ). The experiment 
was performed as follows: Buffer I was incubated in the presence or absence of GT1-7 
cells for 30 min at 37°C. Buffer I from either set was then divided into four groups (in 
duplicate) for: 1) NSB; 2) +ve control (2 µg/ml chymotrypsin); 3) -ve control (boiled for 
15 min to inactivate any peptidases which may be present) and 4) untreated medium. 
1251-GnRH (1 O 000 cpm/100 µI) was added to aliquots (100 µI) from each group and 
incubated at 37°C for 30 min. Thereafter, aliquots from group 2 were boiled to 
inactivate the chymotrypsin. The following was added to each aliquot (200 µI), 100µ1 
(not NSB) antiserum 678 (1 :1 O initial dilution) and 200 µI (300 µI for NSB) PBS-gelatin 
buffer before incubation at 4°C for 18 h. Separation of antibody-bound from free 1251-
GnRH was achieved as described above (*). 
2.2.8 EXTRACTION OF TOTAL CELLULAR RNA 
The method employed for extraction of total cellular RNA from rat hypothalamus and 
GT1 -7 cells was a modification of the method described by Chomczynski and Sacchi 
(1987). Dissected tissue was chilled on ice and homogenized in 0.5 ml lysis buffer. 
GT1-7 cells grown to 80% confluency in 80 cm2 tissue culture flasks (Nunc, 
Copenhagen, Denmark) were washed twice with ice-cold 1 x PBS and lysed in 1 ml 
lysis buffer at room temperature. Both tissue and cell lysates were transferred to 
polypropylene tubes before the addition of 100 µI 2 M sodium acetate (pH 4.0). The 
lysates were mixed by inversion and extracted by the addition of 1 ml phenol (DEPC-
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H20 saturated), 200 µI CHCl3 :isoamylalcohol (49:1) and mixed vigorously for 10 sec. 
After 15 min on ice the mixture was centrifuged at 10 000 x g for 20 min at 4°C, to 
separate the RNA from DNA and proteins. The RNA was recovered from the aqueous 
phase by the addition of 1 ml isopropanol, mixed by inversion and incubated on dry 
ice for 10 min, the precipitate was collected by centrifugation at 10 000 x g for 20 min 
at 4°C. The pellet was resuspended in 500 µI lysis buffer, before the addition of 500 
µI isopropanol, mixed, incubated on dry ice for 10 min and then centrifuged at 10 000 
x g for 20 min at 4°C. The pellet was washed in 75% ethanol (made in DEPC-H20) 
by centrifugation at 1 O 000 x g for 5 min at room temperature. After removal of 
ethanol by aspiration the pellet was air dried and resuspended in 100 µI DEPC-H20. 
The concentration of RNA was determined by spectrophotometric (UV-160A, 
Shimadzu, Japan) absorbance at 260 nm, where one absorbance unit is equivalent 
to 40 µg RNA/ml (Sambrook et al., 1989). RNA yields were between 100 and 200 µg 
per flask with the ratio of 260 nm/280 nm ranging between 1.8 and 2.0. RNA was 
stored at -70°C until needed. 
2.2.9 SYNTHESIS OF PROBE AND REFERENCE RNAs 
The method employed for synthesis of probe and reference RNA was similar to that 
described by Roberts et al. (1989). Template DNA for the in vitro synthesis of probe 
(antisense) and reference (sense) RNA was a complementary DNA (cDNA) clone 
(pGEM3-RAT), representing 338 bp of the rat POA GnRH mRNA inserted into plasmid 
GEM3 (Promega, Madison, WI) at restriction sites Sph I and BamHI (Figure 4) 
(provided by Dr. C. Outlaw, MRC Regulatory Peptides Research Unit, UCT Medical 
School, Cape Town, South Africa). 
The construct was linearized (Nhe I) and probe RNA (642 bp) labelled with [a-32P]UTP 
(3000 Ci/mmole) (Amersham, England) to a high specific activity (2.0 x 108 cpm/µg) 
was transcribed using bacteriophage T7 RNA polymerase. For synthesis of reference 
RNA, the above construct was linearized with BamHI and low-specific-activity (2.0 x 
105 cpm/µg) reference RNA (364 bp) was transcribed using bacteriophage SP6 RNA 
polymerase and a trace amount of [a-32P]UTP. Transcription was terminated by 
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digesting the template DNA with RNase-free DNase I (Boehringer Mannheim, 
Mannheim, Germany). Probe and reference RNAs were phenol-chloroform extracted 
and purified from the mononucleotides through two sequential ethanol precipitations 
in the presence of 5 M NH4Ac and redissolved in 100-200 µI DEPC-H20. Reference 
RNA was quantitated using absorbance at 260 nm, aliquoted, and stored at -70°C in 
the presence of 10-20 U RNasin (Pro mega). 
Nhel 
364 bp 
642 bp 
sense mRNA 
1 33a bp I 
antisense mRNA 
pGEM3-RAT 
2963 bp 
Figure 4: Diagram of pGEM-RAT showing sense (364 bp) and antisense 
(642 bp) transcripts used in the RNase protection assay. 
The antisense oligonucleotide (5'-CC ATA GGA CCA GTG CTG GC-3', # 1, Figure 5) 
used for Northern analysis was directed against the sequence encoding mammalian 
GnRH -1 to 6. The oligonucleotide was 5'-end-labelled using T4 polynucleotide kinase 
in the presence of [y-32P]ATP (3000 Ci/mmole) (Amersham) (Maxam and Gilbert, 
1980). Following purification through a Sephadex G-1 O (Pharmacia, Uppsala, 
Sweden) spun column the 32P 5'-end-labelled probe was ready for use. 
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5'-GCATGGlv,GATTGGTATCCCTTTGGCTTTCACATCCAAACAGA 38 
l~et Gl,, Thr Ile Pro Lys Leu Met Ala Ala Val 
ATG GAA ACG ATC CCC AAA CTG ATG GCC GCT GTT 
*** *** * * *** *** *** *** * X ** 
71 RAT cDNA 
ATC CTC AA.; CTG ATG GCC GGG ATT ( 2 7 ) MOUSE cDNA 
Leu Gly Ile 
Val Leu Leu Thr Val Cys Leu Glu Gly Cys Ser 10~ 
GTT C':'G TTG ACT GTG TGT TTG GAA GGC TGC TCC 
* *** ** *** *** *** *** *** *** *** *** 
CT.:; 
Leu 
CTG CTG ACT GTG TGT TTG GAA GGC TGC TCC 
1 GnRH 10 
Ser G~n His TrD Ser Tvr Glv Leu Ara Pro Glv 
[<-----# 1--------------] 
AGC CAG CAC TGG TCC TAT GGG TTG CGC CCT GGG 
*** *** *** *** *** *** *** *** *** *** *** 
( 6 J) 
. - -, 
.l.) / 
AGC CAG CAC TGG TCC TAT GGG TTG CGC CCT GGG (93) 
Gly Lys Arg Asn Thr Glu His Leu Val Asp Ser 170 
GGG AAG AGA AJ!...T ACT GAA CAC TTG GTT GAT TCT 
** *** *** ** *** *** *** *** *** ** *** 
GGA A.AG AGA AAC ACT GAA CAC TTG GTT GAG TCT 
Glu 
P:1e Gl~ Glu Met Gly Lys Glu Glu Asp Gln Met 
CA.; GAG ATG GGC AAG GAG GAG GAT C~A ATG 
*** *** *** *** *** *** *** * * *** *** *** 
TTC CAA GAG ATG GGC AAG GAG GTG GAT CAA ATG 
Ala Glu Pro Gln Asn Phe Glu Cys Thr Val His 
GCA GAA CCC CAG AAC TTC GAA TGC ACT GTC CAC 
*** *** *** *** ** *** *** ** *** *** *** 
GCA GA.; CCC CAG CAC TTC GAA TGT ACT GTC CAC 
His 
Trp Pro Arg Ser Pro Leu Arg Asp Leu Arg Gly 
TGG CCC CGT TCA CCT CTT AGG GAT CTG CGA GGA 
*** *** *** *** **Y **Y *** *** *** *** *** 
I'GG CCC CGT TCA CCC CTC AGG GAT CTG CGA GGA 
( :.26 l 
2 03 
(:.: 9) 
236 
( 192) 
269 
(225) 
Ala Leu Glu Arg Leu Ile Glu Glu Glu Ala Gly 302 
GCT CTG GAA CGT CTG ATT GAA GAG GAA GCT GGG 
*** *** *** ** *** *** *** *** *** ** z ** 
GCT CTG GAA AGT CTG ATT GAA GAG GAA GCC AGG (258) 
Ser Arg 
Gln Lys Lys Met END 
CAG AAG AAG ATG T.l\A-TGCACTGGCCCAGAAGGATCC-3' 338 
*** *** *** *** ** BamHI 
CAG AAG AAG ATG TAG (273) 
# 1: 5'-CCATAGGACCAGTGCTGGC-3' 
Figure 5: Nucleotide and amino acid sequence of rat and mouse cDNA 
encoding GnRH, indicating the binding site for the oligo-
nucleotide used for Northern analysis. Arrow shows the 
direction and length of the oligonucleotide. Underlined 
are the Sph 1 (blunted) and BamH1 restiction sites (for 
cloning in pGEM3) and the GnRH decapeptide. 
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2.2.10 RNase PROTECTION ASSAY 
The probe (5 x 105 cpm/rxn) was mixed with the total RNA in a final volume of 25 µI 
hybridization solution. For standard curves, the same amount of probe was mixed with 
increasing known amounts of reference RNA (0-50pg) with 20 µg yeast tRNA added 
as carrier. After hybridization for 12 h at 34°C, the unprotected (single-stranded) RNA 
was removed by incubation at 34°C for 1 h with 300 µI RNase solution (diluting the 
DEPC concentration 13-fold to a level which does not inhibit the activity of the 
RNases). The reaction was terminated by the addition of 16 µI 10% SOS and 80 µg 
proteinase K (Sigma, St. Louis, MO), followed by incubation at 37°C for 15 min. 
Samples were phenol-chloroform extracted and precipitated with ethanol and 5 M 
NH4Ac in the presence of 20 µg carrier yeast tRNA, washed with 75% ethanol, dried, 
and dissolved in 5 µI gel-loading buffer. The protected RNA hybrids were 
electrophoresed through a 6% polyacrylamide gel containing 50% (w/v) urea before 
exposure overnight at -70 °C to X-ray film with intensifying screens. Total RNA from 
hypothalamus and muscle (or E.coli) served as positive and negative controls, 
respectively. 32P-labelled DNA markers ranging from 100 to 700 bases were used as 
size standards. 
2.2.11 NORTHERN BLOT ANALYSIS 
The method used was a modification of that described by Virca et al., (1990). Thirty 
µg total RNA was denatured and electrophoresed through a 1.4% (w/v) agarose, 2.2 
M formadlehyde gel and transferred to Hybond-N nylon membranes (Amersham, 
Arlington Heights, IL) (Sambrook et al., 1989). Ethidium bromide staining confirmed 
that the ribosomal RNA's were intact. RNA blots were prehybridized in PIPES buffer 
at 42°C for 15 min before hybridization with the 32P-labelled DNA probe for a further 
18 h. Conditions ensured probe excess. After hybridization, blots were washed twice 
for 10 min in 5% SOS and 1 x SSC at the hybridization temperature. The blots were 
then exposed overnight to X-ray film with an intensifying screen at -70 °c. 
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2.2.12 DATA ANALYSIS AND STATISTICS 
Results of the stimulation experiments are expressed as GnRH released (pg/ml), with 
each figure showing results from a single experiment which was representative of 
three experiments. Data are presented as the mean± SEM (n = 3 to 6). Statistical 
significance of data was evaluated using one-way analysis of variance (ANOVA), 
followed by modified t-test. 
2.3 RESULTS AND DISCUSSION 
An important part in understanding the modulation of GnRH biosynthesis and release 
involves knowledge of those factors which influence the regulation of GnRH mRNA 
gene expression. Prior to the availability of the GT1-7 cell line methodologies for the 
detection of GnRH mRNA in hypothalami were limited by the sensitivity levels of the 
assays. GnRH-synthesizing neurons of which there are only about 1300 in the adult 
rat hypothalamus, show a scattered distribution in the POA and AN (Wray and 
Hoffman, 1986; Merchenthaler, 1991 ). Due to this small population of GnRH neurons, 
only pg quantities of GnRH mRNA can be isolated from each hypothalamus. Thus, 
a method to detect low levels of GnRH mRNA was developed. The approach involved 
optimizing the RNase protection assay, such that GnRH mRNA from individual rat 
hypothalami could be detected. 
After several adjustments to increase the sensitivity of the RNase protection assay the 
methodology as described in sections 2.2.9 and 2.2.10 was selected. The rat cDNA 
probe together with known amounts of reference RNA (0-50 pg) was used to generate 
a standard curve. Figure 6A shows the gel after 1 (probe and standard curve) and 3 
day exposure (hypothalamus and muscle). The sensitivity of the assay was in the 1-2 
pg range, allowing the detection of GnRH mRNA from an individual rat hypothalamus. 
With the availability of the GT1 -7 cells, the RNase protection assay was used to detect 
GnRH mRNA in these cells. As shown in Figure 68, two bands of smaller size than 
expected were detected, indicating that the protected fragment had been digested. 
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As depicted in Figure 5, the sequences of rat and mouse cDNA's encoding GnRH are 
not 100% homologous (Adelman et al., 1986; Mason et al., 1986). As RNase A is an 
endoribonuclease that specifically attacks single-stranded RNA 3' to pyrimidine 
residues, the most likely area of cleavage would be regions of two or more base 
mismatches. As indicated in Figure 5, there are at least three sites where RNase A 
could cleave the RNA:RNA hybrid. Cleavage between X and Y or X and Z would 
result in fragments as shown in Figure 68. As cleavage of· the protected fragment 
may result in data that is quantitatively inaccurate, this method was deemed unsuitable 
for use in the GT1 -7 cells. However, an alternative approach using Northern blot 
analysis allowed for the detection of a single transcript (± 600 bp) in GT1-7 cells 
(Figure 7), confirming the observations by Mellon et al. (1990). 
Probe 
I no Roase I I O I 2 
pg Reference RNA 
2 5 5 10 10 20 20 so I H Mu M 
\::;;: - 309 
Figure 6A: Autoradiogram of gel electrophoresis of GnRH mRNA protected from 
RNase digestion. The gel shows probe and reference RNA (0-50 pg) after 
1 day exposure, and total RNA from H (hypothalamus) and Mu (Muscle) 
after 3 day exposure. M, 32P-labelled DNA marker (Mspl digest of pBR322). 
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309 Figure 68: Autoradiogram of gel electrophoresis 
of GnRH mRNA protected from RNA 
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Figure 7: Northern blot analysis of GT1 -7 cells 
showing expression of GnRH mRNA. 
Thirty µg of total cellular RNA was 
analyzed by RNA blot analysis using 
digestion in GT1 -7 cells. The gel 
shows probe, reference RNA (0-100 
pg), GT1-7 and E.coli total RNA. 
As shown GT1-7 GnRH mRNAwas 
cleaved to give two smaller 
fragments. M, 32P-labelled DNA 
marker (Mspl digest of pBR322). 
antisense oligonucleotide as probe. 
Each lane represents RNA isolated 
from individual flasks of cells. Positions 
of the rRNA markers are indicated. The 
GnRH mRNA is approximately 600 bp. 
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GnRH functions as a central neuromodulator, as well as a hypothalamic hormone. 
The former action of GnRH is probably terminated by enzymatic degradation by EP 
24.15, recently reported to be secreted by GT1-7 cells (M.J.Glucksman, personal 
communication). Since alterations in the rate of GnRH degradation by EP 24.15 may 
p!ay a role in the regulation of its activity (Griffiths et al., 1975; Lasdun et al., 1989), 
it was necessary to resolve whether EP 24.15 was present in the experimental system. 
Evidence against appreciable degradation was provided by incubation of 1251-GnRH for 
30 min at 37°C as described in 2.2.7. As illustrated in Figure 8, no loss of 
immunoreactivity of labeled GnRH was observed upon subsequent testing of either 
group 3 or 4. Hence, it was concluded that EP 24.15 or any other GnRH-degrading 
enzymes have no observable influence in the experimental system, a prerequisite for 
the reliable detection of modulated GnRH levels by method of RIA (2.2.6). 
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Figure 8: Stability of secreted GnRH from GT1-7 cells. 
GnRH degrading activity was investigated by incubation of Buffer I in the 
presence or absence of GT1 -7 cells for 30 min. This medium was divided 
into 4 groups: 1) NSB; 2) C (chymotrypsin 2µg/ml); 3) B (boiled); 4) U (un-
treated). After a 30 min incubation with 1251-GnRH (all groups), antiserum 
678 was added for 18 h at 4°C for detection of 1251-GnRH decapeptide. 
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As discussed in the review there are a number of neuroendocrine factors involved in 
the regulation of GnRH secretion from the hypothalamus. These factors interact at the 
membrane with their receptors which are linked to the activation of various signal 
transduction pathways. Previous in vitro studies have shown that the protein kinase-A 
and -G (PKA and PKG) pathways are dually involved in the regulation of GnRH gene 
expression and release (Ojeda et al., 1986; Lee et al., 1990). Furthermore, studies 
using hypothalamic slices have shown that depolarization of GnRH neurosecretory 
neurons with high concentrations of K+ causes rapid release of GnRH via VSGG 
(Drouva et al., 1981 ). The present study examined basal GnRH release from GT1-7 
cells and responses to the following secretagogues: L-GLU for activation of ionotropic 
and metabotropic GLU receptors, K+ for depolarization, forskolin for activation of the 
cAMP-PKA pathway and PMA for the PKG-dependent pathway. The dependency of 
GnRH secretion on extracellular Ga2+ was also investigated. 
GnRH release (as detected by RIA) from static GT1-7 cells incubated in Buffer I was 
monitored over 15 min (Figure 9A) or 30 min (Figure 9B) periods. The cells released 
GnRH spontaneously (basal release) and treatment with 1 O mM L-GLU, 60 mM K+, 
1 O µM forskolin and 50 nM PMA all significantly stimulated release above basal levels 
(n=3, p<0.05,p<0.005,p<0.02,p<0.001, respectively). These data corroborate the work 
by Mellon et al. (1990), who found that GT1-7 cells secrete GnRH spontaneously and 
that this release is linked to propagated action potentials involving fast Na+ channels. 
The observation that L-GLU enhances GnRH secretion is consistent with recent 
studies by Spergel et al. (1994). This group observed that activation of NMDA and 
AMPA/kainate receptors lead to Ga2+ influx followed by an increase in GnRH secretion. 
In addition, these results show that both the PKG and PKA pathways are functional 
in the GT1-7 cells. Interactions between both transducing systems may provide a 
mechanism for enhanced GnRH release (Ojeda et al., 1986; Lee et al., 1990). Recent 
studies using static GT1-7 or GT1 -3 cells have reported that although activation of the 
PKG pathway acutely increased GnRH release, prolonged treatment resulted in a 
progressive reduction in GnRH mRNA levels (Bruder et al., 1992; Wetsel et al., 1993; 
Yu et al., 1994). Also, while PKA activation stimulated GnRH release, GnRH mRNA 
levels were either unchanged (Wetsel et al., 1993) or decreased (Yu et al., 1994). 
39 
** 
400 
-
,.... 
~ 
....____ 
~ 
p., 300 
"d 
Cl) 
C'/l 
cu 
Cl) 
- 200 Cl) 
' 
::r:: 
p:: 
C: 
c.., 100 
0 L---
L-GLU K+ Basal 
lOmM 60mM 
Figure 9A: Effect of L-GLU and K+ on GnRH release from GT1-7 cells. 
Treatment of GT1-7 cells with 1 O mM L-GLU and 60 mM K+ 
for 15 min. •• P< 0.05; ··, P< 0.005 vs. control (Basal) 
(n=3 for each group). 
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Figure 98: Effect of forskolin and PMA on GnRH release from GT1-7 cells. 
Treatment of GT1-7 cells with 10 µM forskolin and 50 nM PMA 
for 30 min. •• P< 0.02; ••• P< 0.001 vs. control (Basal) (n=3 for 
each group). 
40 
The role of extracellular Ca2+ in mediating basal, K+- and forskolin-stimulated release 
of GnRH from GT1-7 cells was investigated over a 15 min period (Figure 10). The 
removal of Ca2+ from Buffer I had no effect on basal GnRH release, but resulted in a 
significant reduction to basal levels for the K·- and forskolin- stimulated GnRH release 
(n=3, p< 0.001 ). The results demonstrate that influx of extracellular Ca2 .. is required 
for the K+- and forskolin-enhanced GnRH release. In support of these findings, 
Martinez de la Escalera et al. (1992a) and Wetsel et al. (1992) have shown that 
removal of extracellular Ca2+ for a prolonged period (4h) results in the progressive 
reduction of the amplitude and eventually in the absence of pulsatile GnRH release 
from GT1-7 cells. The unchanged basal levels to short-term (15 min) removal of Ca2·, 
suggest that intracellular Ca2• stores (or residual extracellular Ca2·) can transiently 
maintain episodic GnRH release. Taken together, these observations suggest that 
activation of voltage-dependent high-threshold-Ca2+ conductances are rapidly triggered 
by membrane depolarization, resulting in an increased rate of Ca2• influx and quantal 
release of GnRH. 
In other studies pulsatile GnRH release from GT1-7 cells was markedly attenuated in 
the presence of nifedipine, an antagonist of dihydropyridine VSCC (Krsmanovic et al., 
1992). Nifedipine also reduced both intracellular Ca2• concentration [Ca2·1i and basal 
GnRH release in a dose-dependent manner. Also, depolarization with high K+ 
increased [Ca2+L and GnRH release in an extracellular Ca2+ dependent and nifedipine-
sensitive manner. Such a profile of Ca2+ response to depolarization by high K+ is 
consistent with the presence of L-type VSCCs. Further studies with GT1-7s and rat 
AN-ME using Bay K 8644, a dihydropyridine Ca2• channel agonist, increased basal 
and K·-induced elevations of [Ca2•L and GnRH secretion. These effects are a result 
of Bay K 8644 increasing entry of extracellular Ca2• via L-type VSCCs (Kalra et al., 
1991; Krsmanovic et al., 1992). Kalra et al. (1991) also demonstrated that (.l)-
conotoxin, an antagonist at N- and L-type VSCC, decreased the KCl-induced GnRH 
release by 40-60% from in vitro rat AN-ME. These results suggest that both N- and 
L- Ca2• channels are present in GnRH neurons and that influx of extracellular Ca2• via 
these channels is an important event in depolarization-induced release of GnRH from 
the AN-ME of male rats. 
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Figure 10: Effect of extracellular Ca2+ removal on GnRH release from GT1-7 cells. 
Basal, K· and forskolin stimulated release was determined in the presence 
of(+) or absence(-) of extracellular Ca2+ for 15 min. ·, P< 0.001 vs. 
control (+Ca2+) (n=3 for each group). 
lonomycin which stimulates Ca2+ influx independent of VSCC, significantly increased 
GnRH release from GT1-3 cells in a time-dependent fashion. The maximal increase 
in GnRH release by 1 µM ionomycin was observed after only 10 min of treatment. 
Interestingly, as mentioned for activation of the PKC and PKA pathways, ionomycin 
resulted in a dose-dependent reduction in GnRH mRNA expression after 24 h of 
treatment (Yu et al., 1994). It is postulated that some of the secretagogues may 
transactivate other second messenger pathways, however, the exact mechanism of 
the divergent effects on the synthesis and secretion of GnRH remain to be elucidated. 
Collectively, the above results characterized the intracellular responses to various 
secretagogues in GT1-7 cells. Knowledge of the molecular mechanisms by which 
second messenger pathways regulate the transcription, processing, and secretion of 
GnRH forms a foundation for understanding the physiological basis for the 
neuroendocrine regulation of reproduction. Clearly, these cells provide an excellent 
opportunity for the analysis of these mechanisms. 
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3: DEMONSTRATION OF GnRH BINDING SITES AND 
EFFECTS OF GnRH ANALOGS ON GnRH RELEASE 
FROM GT1-7 CELLS. 
3.1 INTRODUCTION 
The ability of cells to regulate their own metabolism and growth via cellular products 
has been termed autofeedback or autocrine regulation. Classically the term autocrine 
has referred to work within the fields of oncogene and growth factor research. 
Researchers within the field of neuroendocrinology however, introduced the concept 
of "ultrashort loop feedback", whereby hypothalamic hormones could regulate their 
own synthesis, storage, and/or release (Hyppa et al., 1971; Sporn and Roberts, 1985). 
The factors that are known to function via an autocrine mechanism include bombesin, 
transforming growth factor-a,-p (TGF-a, TGF-P) and peptides related to platelet-
derived growth factor (PDGF) (Sporn and Roberts, 1985). In addition, the presence 
of ir-GnRH and GnRH mRNA in breast carcinoma cells known to have GnRH-binding 
sites has lead to the suggestion that GnRH may serve an autocrine role within these 
cells (Harris et al., 1991 ). There are also several reports that document the possible 
existence of ultrashort feedback circuits for a number of neurotransmitters and 
neuropeptides. These include NE (via ~-adrenoceptors), l}-endorphin (via µ-
receptors}, somatostatin (SS), growth hormone-releasing factor (GAF), thyrotropin 
releasing hormone (TRH), oxytocin, GAL and CRH (Lumpkin et al., 1981; Lumpkin et 
al., 1983; Moos et al., 1984; Ohta et al., 1985; Lumpkin et al., 1985; Ono et al., 1985; 
Epelbaum et al., 1986; Richardson and Twente, 1986; Kelly et al., 1990; MacDonald 
et al., 1992; de los Frailes et al., 1992; Lopez et al., 1992). 
The review showed that the excitation of GnRH neurons is subject to modulation by 
hormones or neurotransmitters released by other cells. Moreover, as supported from 
in vitro and in vivo studies, GnRH has been proposed to exert an inhibitory action on 
its own secretion (1.2.2). Prior to an investigation into the existence of an ultrashort 
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feedback mechanism within GT1-7 cells it was essential to determine the presence of 
specific GnRH receptors (binding sites) and GnRH receptor mRNA in GT1-7 cells. 
The availability of a GnRH-responsive pituitary cell line of the gonadotrope lineage 
(aT3-1) provided a model system for comparative GnRH receptor binding studies with 
the putative binding site on the GT1-7 cells (Windle et al., 1990). The receptors in 
aT3-1 cells show specificity for different GnRH analogs, with dissociation constants 
very similar to those found in normal rat and mouse pituitary (Table 3). 
Table 3. Comparison of the GnRH receptor on mouse, aT3-1, and rat 
anterior pituitary membrane homogenates (Horn et al., 1991 ). 
Mouse aT3-1 I Rat 
Kd (nM) 0.51 I 0.50 ! 0.20 
~. Dissociation constant of [DAla6,Me-Leu7,Pro9-NEt]-GnRH 
I 
I 
GnRH receptor binding studies were thus performed on both the aT3-1 and GT1-7 cell 
lines. In addition, cloning of the mouse GnRH receptor provided the necessary tools 
to determine by method of polymerase chain reaction (PCR) if the GT1-7 cells express 
mRNA for this receptor (Tsutsumi et al., 1992). The results demonstrated that the 
GnRH analog, Ant 26, bound to specific receptors in GT1-7 cells and that these cells 
have the capacity to synthesize receptors for GnRH. 
The above findings enabled an investigation to determine whether GnRH influences 
the control of its own release through autoreceptors located on GnRH-containing 
neurons. This was accomplished by examining basal and secretagogue-induced 
GnRH release from GT1-7 cells in the presence or absence of various GnRH analogs. 
Exposure of static GT1-7 cells to the GnRH antagonist (Ant 27) resulted in enhanced 
basal, K+- and forskolin-stimulated GnRH release. However, GnRH content was 
shown to be unchanged by the analog. A preliminary account of some of these results 
has been reported (Pithey et al., 1992). 
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3.2 MATERIALS AND METHODS 
The methodology used was identical to that described in section 2.2, except for the 
following: 
3.2.1 CHEMICALS AND BUFFERS 
Poly-L-ornithine (Sigma, St. Louis, MO); 2.5 x reverse transcriptase (RT) Taq buffer 
for RT-PCR consisted of 168 mM Tris-HCI (pH 8.8), 41.5 mM (NH4hS04 , 16.8 mM 
MgCl2, 25 mM ~-mercaptoethanol, 0.42 mg/ml BSA. 
3.2.2 PEPTIDES AND ANT/SERA 
Ant 26 
GnRH[His50-Arg6-Trp7-
Tyr8] 
GnRH[D-Ala6-N-MeLeu7 , 
Pro9NEt] 
Ant 27 
Ant 140-36 
Ac-D-p-CIPhe-Ac-O-p-CIPhe-D-Trp-Ser-Tyr-D-Lys-
Leu-Arg-Pro-D-AlaNH2 (D.H. Coy, Tulane University 
Medical Center, New Orleans, LA) 
pG lu-His-Trp-Ser-His-0-Arg-Trp-Tyr-Pro-GlyN H2 
(R.C. del. Milton) 
pGlu-His-Trp-Ser-Tyr-0-Ala-N-MeLeu-Arg-ProN Et 
(R.C. del. Milton) 
Ac-D-Nal-D-Me-4-CIPhe-D-Trp-Ser-N-lsopropylLys-
D-Tyr-Leu-Arg-Pro-D-AlaNH2 
(R.C. del. Milton) 
Ac-D-2-Nal-D-Me-CIPhe-D-Trp-Ser-D-Pro-D-N-
lsopropylLys-Leu-N-lsopropylLys-Pro-D-AlaNH2 
(R.W. Roeske, Indiana University, Indianapolis, IN) 
Three of the above GnRH analogs had highly increased biopotency, while one was 
without biological activity. The binding potencies relative to GnRH were 6, 12, 11 and 
32 times for GnRH[His50-Arg6-Trp7-Tyr8], GnRH[D-Ala6-N-MeLeu7,Pro9NEt], Ant 27 and 
Ant 26, respectively. These potencies were assessed by receptor binding to rat 
pituitary GnRH receptor (Perrin et al., 1980; C. Flanagan, personal communication). 
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The inactive analog was Ant 140-36. The greater biological activity of GnRH analogs 
having amino acid substitutions in positions 5 and 6 indicate that their increased 
biological activity (compared to those having a Tyr5-Gly6 bond) might be caused by an 
increased resistance to enzymatic degradation. Stock solutions of peptides (1 mM) 
were made up in dH20 or 5% (v/v) acetonitrile/5% (v/v) methanol (agonists), or 20 % 
(v/v) propylene glycol (antagonists), and stored at -20°C. For experimental purposes 
stock solutions were dissolved just before use in incubation medium. 
Antiserum EL-14 (1: 50 000 initial dilution), was provided by W.E. Ellinwood 
(Department of Physiology, Oregon Health Sciences University, Portland, OR). This 
antiserum requires that both the N- and C-termini of GnRH be intact and thus 
recognizes only processed GnRH and not GnRH fragments (Ellinwood et al., 1985). 
To assess whether any of the GnRH analogs might interfere with the measurement 
of endogenous GnRH by RIA, the displacement of 1251-GnRH from the anti-GnRH 
antisera by each analog was determined. The results are summarized in Table 4. 
Table 4 : Percentage binding of 1251-GnRH to anti-GnRH antisera in the presence of 
GnRH analogs. 
GnRH GnRH[His5DArg6 GnRH[DAla6NMe Ant 140- Ant 27 
analog Trp7Tyr3] Leu7,Pro~ 36 
Antisera 1076 1076 1076 1076 EL14 
Conc.[M] % BINDING 
10·9 100 100 100 100 100 
1 o·s 100 100 100 100 100 
10-7 100 100 100 100 96* 
10-6 100 100 100 100 85* 
* displacement of 1251-GnRH by analog, mimicking presence of GnRH within RIA. 
Since Ant 27 cross-reacts with EL-14 the antiserum of choice for all the analogs was 
1076. No difference in levels of secreted GnRH was detected by antiserum EL-14 or 
1076 (data not shown). Ab 678 was not available for these studies. 
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3.2.3 BINDING STUDIES 
GT1-7 and aT3-1 cells (supplied by P.L. Mellon) were maintained and cultured for 
experimental purposes as described in 2.2.3, except that the 6-well plates had 
previously been coated with poly-L-ornithine (15 µg/ml). In addition, the cells were 
cultured to confluence, after which serum-free medium was added for a further 24 h. 
After 24 h the cells were washed twice in buffer I (1 ml/well). Binding was initiated by 
the addition of 1 ml buffer I containing dilutions of unlabeled Ant 26 and 
1251-Ant 26 
(1 x 105 cpm/well). After 1 h at 4°C the buffer was aspirated off and the cells were 
solubilized with a 1 % Triton X-100 / 0.05% NaOH solution. The cell lysates 
(containing the bound (8) Ant 26) were counted in an autogamma spectrometer. All 
binding studies were performed in triplicate. Maximal binding (80 ) (20-21 % of TC) was 
determined in the absence of unlabeled Ant 26 and non-specific binding (NSB) (8-10% 
of TC) by the addition of 1 o.s M Ant 26. 
Iodination of Ant 26 was carried out as described in 2.2.6 for GnRH, however 50 µI 
N~S20 5 (6 mg/ 5ml 0.5 M NaH2P04 (pH 7.6)) was added to stop the reaction and a 
gradient of O to 80% CH3CN was run for elution of the peptide from the column. 
Figure 11 shows two well-separated peaks of radioactivity, the first representative of 
unreacted iodide, and the second 1251-Ant 26. 
Figure 11 : Iodination of Ant 26. 
The first peak shows 
unreacted iodide and 
2.-----------------, 
1.5 
1 
0.5 
the second 1251-Ant26. 0 Lee4~~MiM ................... -=-___i__..:~ 
0 5 1 0 15 20 25 30 35 40 
FRACTION NUMBER 
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3.2.4 RT-PCR OF GnRH RECEPTOR mRNA 
Total RNA from GT1-7 cells was prepared as described in section 2.2.8. For RT-PCR 
reactions, two oligonucleotide GnRH primers were synthesized based on the reported 
cDNA sequence for the mouse GnRH receptor (Tsutsumi et al., 1992). As depicted 
in Figure 12, the sense oligonucleotide (5'-CAGTGGTATGCTGGGG-3', *primer1) 
overlaps with the post transmembrane loop II, whereas the antisense oligonucleotide 
(5'-TTCTTGG ACTGATTCATCTG-3', primer 2) corresponds to post transmembrane 
loop V. These primers yield a 458 bp PCR product. Primer 1 was 5'-end-labelled 
using T4 polynucleotide kinase in the presence of [y-32P]ATP (3000 Ci/mmole) 
(Amersham) (Maxam and Gilbert, 1980). Following purification through a Sephadex 
G-10 (Pharmacia, Uppsala, Sweden) spun column the 32P 5'-end-labelled primer 
(*primer1) was ready for use. cDNA synthesis was performed using sense (0.1 ng/ml) 
or total RNA (1 µg/ml) in a RT reaction. 10 µI RNA (10 ng for total, 1 pg for sense) 
was added to 1 O µI 2.5 x RT Taq buffer containing 1 µI primer 2 (50 pmoles), heated 
to 94°C for 2 min and snap-cooled on dry ice. 1 O µI of 2.5 x RT Taq buffer with 3 U 
avian myeloblastosis virus (AMV) RT (Life Sciences, St. Petersburg, FL), 1 U RNasin, 
and 1 mM each of dATP, dCTP, dGTP, and dTTP was added to the cold annealing mix 
and incubated at 42°C for 15 min, 50°C for 15 min and 55°C for 30 min. The cDNA 
product was then amplified by the addition of 4 µI 2.5 x RT Taq buffer, 5 µI *primer1 
and 2.5 U Taq DNA polymerase (Promega). A paraffin oil overlay was applied and 
20 PCR cycles were performed. Each cycle of amplification consi~ted of a 40 sec 
denaturation at 94°C, followed by 2 min annealing (56°C) and 2 min extension (72°C) 
steps. After PCR, 8 µI gel-loading buffer was added to the samples before heating to 
90°C for 2 min before electrophoresis through a 6% polyacrylamide, 50% (w/v) urea, 
1 x TBE gel. The gel was dried under vacuum and exposed to X-ray film. 
3.2.5 ANALOG STUDIES 
The protocols described in sections 2.2.4, 2.2.5, and 2.2.6 were adhered to except 
where stated. Experiments involving the use of agonists and antagonists required 
preincubation for 18 h or 30 min (as indicated in the appropriate figure legends) in 
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ACGAGAGGGACTCCACTCTTGAAGCCTGTCCTTGGAGAAAT -1 
Met Ala Asn Asn Ala Ser Leu Glu Gln Asp Pro Asn His Cys Ser Ala Ile Asn Asn 19 
ATG GCT AAC AAT GCA TCT CTT GAG CAG GAC CCA AAT CAC TGC TCG GCC ATC AAC AAC 57 
Ser Ile Pro Leu Ile Gln Gly Lys Leu Pro Thr Leu Thr Val Ser Gly Lys Ile Arg .38 
AGC ATC CCC TTG ATA CAG GGC AAG CTC CCG ACT CTA ACC GTA TCT GGA AAG ATC CGA 114 
I 
Val Thr Val Thr Phe Phe Leu Phe Leu Leu Ser Thr Ala Phe Asn Ala Ser Phe Leu .57 
GTG ACC GTG ACT TTC TTC CTT TTC CTA CTC TCT ACT GCC TTC AAT GCT TCC TTC TTG 171 
Leu Lys Leu Gln Lys Trp Thr Gln Lys Arg Lys Lys Gly Lys Lys Leu Ser Arg Met .76 
TTG AAG CTG CAG AAG TGG ACT CAG AAG AGG AAG AAA GGA AAA AAG CTC TCA AGG ATG 228 II 
Lys Val Leu Leu Lys His Leu Thr Leu Ala Asn Leu Leu Glu Thr Leu Ile Val Met .95 
AAG GTG CTT TTA AAG CAT TTG ACC TTA GCC AAC CTG CTG GAG ACT CTG ATC GTC ATG 285 
Pro Leu Asp Gly Met Trp Asn Ile Thr Val Gln Trp Tyr Ala Gly Glu Phe Leu Cys 114 [----*primerl------>] 
CCA CTG GAT GGG ATG TGG AAT ATT ACT GTT CAG TGG TAT GCT GGG GAG TTC CTC TGC 342 
III 
Lys Val Leu Ser Tyr Leu Lys Leu Phe Ser Met Tyr Ala Pro Ala Phe Met Met Val 133 
AAA GTT CTC AGC TAT CTG AAG CTC TTC TCT ATG TAT GCC CCA GCT TTC ATG ATG GTG 399 
Val Ile Ser Leu Asp Arg Ser Leu Ala Ile Thr Gln Pro Leu Ala Val Gln Ser Asn 152 
GTG ATT AGC CTG GAC CGC TCC CTG GCC ATC ACT CAG CCC CTT GCT GTA CAA AGC AAC 456 
IV 
Ser Lys Leu Glu Gln Ser Met Ile Ser Leu Ala Trp Ile Leu Ser Ile Val Phe Ala 171 
AGC AAG CTT GAA CAG TCT ATG ATC AGC CTG GCC TGG ATT CTC AGC ATT GTC TTT GCA 513 
Gly Pro Gln Leu Tyr Ile Phe Arg Met Ile Tyr Leu Ala Asp Gly Ser Gly Pro Thr 190 
GGA CCA CAG TTA TAT ATC TTC AGG ATG ATC TAC CTA GCA GAC GGC TCT GGG CCC ACA 570 
Val Phe Ser Gln Cys Val Thr His Cys Ser Phe Pro Gln Trp Trp His Gln Ala Phe 209 
GTC TTC TCG CAA TGT GTG ACC CAC TGC AGC TTT CCA CAG TGG TGG CAT CAG GCC TTC 627 
V 
Tyr Asn Phe Phe Thr Phe Gly Cys Leu Phe Ile Ile Pro Leu Leu Ile Met Leu Ile 228 
TAC AAC TTT TTC ACC TTC GGC TGC CTC TTC ATC ATC CCC CTC CTC ATC ATG CTA ATC 684 
Cys Asn Ala Lys Ile Ile Phe Ala Leu Thr Arg Val Leu His Gln Asp Pro Arg Lys 247 
TGC AAT GCC AAA ATC ATC TTT GCT CTC ACG CGA GTC CTT CAT CAA GAC CCA CGC AAA 741 
Leu Gln Met Asn Gln Ser Lys Asn Asn Ile Pro Arg Ala Arg Leu Arg Thr Leu Lys 266 
[<-------primer2---------] 
CTA CAG ATG AAT CAG TCC AAG AAT AAT ATC CCA AGA GCT CGG CTG AGA ACG CTA AAG 798 VI 
Met Thr Val Ala Phe Ala Thr Ser Phe Val Val Cys Trp Thr Pro Tyr Tyr Val Leu 285 
ATG ACA GTC GCA TTC GCT ACC TCC TTT GTC GTC TGC TGG ACT CCC TAC TAT GTC CTA 855 
Gly Ile Trp Tyr Trp Phe Asp Pro Glu Met Leu Asn Arg Val Ser Glu Pro Val Asn 304 
GGC ATT TGG TAC TGG TTT GAT CCA GAA ATG TTG AAC AGG GTG TCA GAG CCA GTG AAT 912 
VII 
His Phe Phe Phe Leu Phe Ala Phe Leu Asn Pro Cys Phe Asp Pro Leu Ile Tyr Gly 323 
CAC TTT TTC TTT CTC TTT GCT TTC CTA AAC CCG TGC TTC GAC CCA CTC ATA TAT GGG 969 
Tyr Phe Ser Leu 327 
TAT TTC TCT TTG TAGTTGGGAGACTACACAAGAACTCAGATAGAAATAAGGTAACTAATTGCACCAATTGA 1040 
GAATAAACTCAAAGCTTTTGACACACTTATATACAAGGCAGGGTTTAAGGTTAGATTATCAACCTTGTTTTTGTA 1115 
CAGAGTTTGTTGTTAGAGCTTCAGAAGACCTTCAAAAAC 1185 
*primerl: 5'-CAGTGGTATGCTGGGG-3' 
primer2 : 5'-TTCTTGGACTGATTCATCTG-3' 
Figure 12: Nucleotide and deduced amino acid sequence of mouse cDNA encoding 
GnRH receptor, indicating the binding sites for primers used for RT-PCR. 
Putative transmembrane regions I-VII are lined. 
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serum-free medium with replacement of analogs for the stimulation period. For the 
determination of cellular GnRH content, cells were lysed with 1 ml of 1 % Triton X-100 
per well before measurement by RIA (2.2.6). 
3.2.6 DA TA ANALYSIS 
ED50 (effective dose required to displace 50% of 
1251-Ant 26) values were estimated by 
four-parameter non-linear curve fitting using Sigmaplot (Jandel Scientific, Corte 
Madera, CA). % Specific binding= (B-NSB/80 -NSB) x 100. The SEMs for the binding 
studies are not included as they were extremely low and the error bars would not be 
visible on the graph. Data analysis for the analog studies were as described in 2.2.12. 
3.3 RESULTS AND DISCUSSION 
Numerous neuroendocrine factors are implicated in the functional control of GnRH 
neurons. Many questions remain however, concerning the location of the receptors 
and whether the effects are exerted directly or indirectly on the GnRH neuron. While 
interconnections between GnRH neurons in the rat POA and in GT1-7 cells provide 
the neuroanatomical basis for GnRH autoregulation, the presence of GnRH receptors 
on these cells remain an integral component of this mechanism (Leranth et al., 1985b; 
Liposits et al., 1991 ). Thus, receptors for GnRH in GT1-7 cells were determined by 
binding studies and detection of GnRH receptor mRNA by method of PCR. 
The GnRH antagonist (Ant 26) was used to characterize GnRH receptors in 
monolayered GT1-7 and aT3 cells. The displacement of 1251-Ant 26 by unlabeled Ant 
26 is illustrated in Figure 13. The estimated ED50 values for Ant 26 in aT3-1 and GT1 -
7 cells were 1.5 and 19 nM, respectively. The difference in apparent binding affinity 
suggest the presence of two classes of receptor. In addition, the cells were capable 
of binding GnRH in a similar manner on Day 3 or 4 of culture, indicating GnRH 
receptor integrity in this system. All these observations suggest that such an in vitro 
cell system would be appropriate for studying GnRH receptor characteristics under 
different physiological conditions. 
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Figure 13: Demonstration of binding sites in GT1-7 and aT3-1 cells. 
GT1-7 and aT3-1 cells were incubated in the presence of 
different concentrations of Ant 26 together with 1251-Ant 26 
for 1 h at 4°C. The above figure shows the displacement of 
1251-Ant 26 binding to GT1-7 and aT3-1 cells by unlabeled 
Ant 26. Dotted lines indicate ED50 values. B0 refers to 
binding of 1251-Ant 26 in the absence of competing ligand. 
Furthermore, the above studies are supported by recent work by Krsmanov1c et al. 
(1993) who showed that GnRH binds with high affinity to specific receptors in GT1-7 
cells in a dose-, time-, and temperature-dependent manner. Their results estimated 
IC50 values of 12 nM for GnRH, 2nM for the GnRH antagonist [D-pGly1,D-?he2,D-
Trp3·6]GnRH, and 2.4 nM for the GnRH agonist des-Gly1°[DAla6]GnRH N-ethylamide. 
No comparative studies with aT3-1 cells were presented. 
As depicted in Figure 12, the isolated GnRH receptor cDNA encodes a 327 am;no acid 
protein that has seven putative transmembrane regions. Intriguingly, it is unique 
among G protein-coupled receptors in that the predicted sequence lacks a carboxyl-
terminal cytoplasmic domain (Tsutsumi et al., 1992). For the detection of receptor 
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mRNA in GT1-7 cells, different methodologies were employed. Firstly, two other 
groups documented the expression of D1-dopaminergic and ~1-adrenergic receptor 
mRNAs in GT1-7 cells by Northern analysis. Interestingly, ~1-adrenergic receptor 
mRNA was present in lower amounts in GT1-7 cells than in brain (Martinez de la 
Escalera et al., 1992b; Findell et al., 1993). In other studies, analysis of GT1-7 cells 
by PCR revealed the presence of NPY1 and GABAA receptor subunit mRNA (Hales 
et al., 1992; Besecke et al., 1993). Thus, detection of mRNA encoding GnRH receptor 
in GT1-7 cells involved both Northern (2.2.10) and PCR (3.2.4) methodology. 
However, both approaches proved to be unsuccessful. · It was concluded that the 
Northern was not sensitive enough to detect the low levels of GnRH receptor mRNA 
assumed to be present in GT1-7 cells. The PCR was done only once, the result of 
which was inconclusive. More than one band was present, suggesting non-specific 
binding to be the cause. Further optimization of the assay would include for example, 
changing the concentration of the oligonucleotide, its design, the Mg
2
+ concentration, 
or possibly the temperature of the reactions. In view of the other work being 
undertaken there was insufficient time to pursue this further. While the aforementioned 
methodologies were ineffective, analysis of GT1-7 RNA by Krsmanovic et al. (1993), 
revealed two mRNA species (1.6 and 3.5 kb) similar to those present in aT3-1 cells 
and in the mouse pituitary gland. The proportions of the receptor transcripts in aT3-1 
and GT1-7 cell lines were also similar, with a predominance of the 3.5 kb species. In 
earlier studies, both transcripts were shown to encode functional receptors when 
expressed in Xenopus laevis oocytes (Reinhart et al., 1992). It is proposed that the 
two mRNAs may have different stabilities or be differently regulated in response to 
various physiological situations in vivo. 
The above findings have established that GT1-7 cells contain a specific binding site 
for GnRH as well as express mRNA for the GnRH receptor cloned from aT3-1 cells. 
Since GT1-7 and aT3-1 cells express similar GnRH receptor mRNA, but have distinct 
binding affinities for Ant 26, it is proposed that in the two cell lines the post-
translational processing of the receptor differs. We cannot, however, discount the 
possibility that GT1-7 cells represent a transformed cell line that may express 
receptors not normally seen on GnRH neurons. 
52 
Although an ultrashort loop feedback inhibition of GnRH secretion has been 
demonstrated both in vivo and in vitro, the mechanism and circuitry of such an effect 
remain to be defined (1.2.2). Since the GT1-7 cells express the mRNA for GnRH and 
its receptor, the synapse-like connections observed among the GT1 -7 cells may 
represent areas of the neuron where secretory vesicles congregate in close proximity 
to receptors (Mellon et al., 1990; Liposits et al., 1991). These findings provided the 
basis for the existence of a functional ultrashort feedback mechanism in the GT1 -7 cell 
line. The current studies utilized GnRH analogs as tools to evaluate whether GnRH 
may regulate its own release via an ultrashort loop feedback mechanism. 
Initially GT1-7 cells were exposed to either to GnRH[His5D-Arg6-Trp7-Tyr8] or the 
superactive GnRH agonist, GnRH[D-Ala6-N-MeLeu7,Pro9NEt], for 18 h or 30 min, 
respectively. Thereafter, basal and secretagogue-stimulated GnRH release was 
determined over a 15 min or 30 min period. As shown in _Figures 14A and B, neither 
agonist altered GnRH secretion under the conditions mentioned in the figure legends. 
It was concluded that the agonists were ineffective due to the high levels of 
endogenous GnRH. In other words, GnRH levels were already at maximal for the 
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Figure 14A: Effect of different concentrations of GnRH[His5D-Arg6-Trp7-Tyr8] on GnRH 
release from GT1-7 cells. 
After GT1-7 cells were preincubated with GnRH [His5D-Arg6-Trp7-Tyr8] for 
18h, basal and K+-stimulated GnRH release was determined over 15 min. 
No concentration-dependent effect was observed (n=3 for each group). 
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Figure 148: Effect of 1 µM GnRH[DAla6-NMeleu7,Pro9NEt] on GnRH release from 
GT1-7 cells. 
After GT1-7 cells were preincubated with GnRH[DAla6-NMeleu7 ,Pro9NEt] 
for 30 min, basal, forskolin and PMA-stimulated GnRH release was 
determined over 30 min. No significant difference to control groups (no 
agonist) was observed (n=3 for each group). 
An alternative approach involved the use of a highly potent, but non-cross-reacting 
antagonist (Ant 27). After GT1-7 cells were co-incubated with Ant 27 for either 30 min 
or 18 h, basal and K+-induced GnRH release was determined over 15 min. As shown 
in Figure 15A, Ant 27 significantly increased basal GnRH release over control levels 
at doses of 1 O nM (P< 0.05), 100 nM and 1 µM (p< 0.001 ). Similarly, as shown in 
Figure 158, preincubation for 18 h with Ant 27, resulted in a dose-dependent increase 
in basal GnRH release (p< 0.001 ). These results are consistent with the in vitro 
studies by Valenca et al. (1987), who showed that a different antagonist enhanced 
basal GnRH secretion in a concentration-dependent manner. In addition, Ant 27 
further augmented K+-induced GnRH release (Figures 15A and 8). Preincubation for 
30 min with 100 nM (p< 0.01) and 1 µM Ant 27 (p< 0.001) or 18 h with 1 µM Ant 27 
(p< 0.001) enhanced K+-stimulated GnRH release. These findings are in accord with 
the observations of Krsmanovic et al. (1993) who demonstrated that exposure of 
perifused GT1-7 neurons to a GnRH agonist analog (1 O nM) caused a transient 
elevation of GnRH release and subsequent suppression of the basal pulsatile 
secretion. Their results are presented in Figure 16. 
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Figure 15A: Effect of different concentrations of Ant 27 on GnRH release from 
GT1-7 cells. 
After GT1-7 cells were preincubated with Ant 27 for 30 min, basal 
and K+-stimulated GnRH release was determined over 15 min. ·, P< 
0.05; ··, P<0.01; ···, P< 0.001 vs. control group (no antagonist) (n=5 
for each group). 
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Figure 158: Effect of different concentrations of Ant 27 on GnRH release from 
GT1-7 cells. 
After GT1-7 cells were preincubated with Ant 27 for 18h, basal and 
K+-stimulated GnRH release was determined over 15 min.*,P< 0.001 
vs. control group (no antagonist) (n=5 for each group). 
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Figure 16: Averaged data (n=4) of GnRH release under basal conditions (bar a), 
and 1 O min (barb) and 60 min (bar c) after the beginning of agonist 
stimulation (Krsmanovic et al., 1993). 
Furthermore, as shown in Figure 17, co-incubation with 1 µM Ant 27 for 30 min, 
followed by a 30 min stimulation period, significantly increased GnRH release both 
basally and in response to 1 O µM forskolin (p< 0.001 ). In contrast, 1 µM Ant 140-36 
(inactive analog) was without effect. These results are supported by recent studies 
whereby preincubation of static GT1-3 cells for 1 h with 100 nM Ant 27 was shown to 
enhance basal and forskolin-stimulated GnRH release (after 1 h) (Yu et al., 1994). 
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Figure 17: Effect of Ant 27 and Ant 140-36 on GnRH release from GT1-7 cells. 
After GT1-7 cells were preincubated with either Ant 27 or Ant 140-36 
for 30 min, basal and forskolin-stimulated GnRH release was determined 
over 30 min. ·, P< 0.05; ··,< 0.001 vs. control group (no antagonists) 
(n=3 for each group). 
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Conversly, there was no significant effect on cellular GnRH content after 30 min or 18 
h treatment with 1 O nM, 100 nM or 1 µM Ant 27 (Figure 18). The above data support 
previous in vitro studies with rat MBH where although a GnRH agonist inhibited both 
basal and K+·induced GnRH release, GnRH content remain unchanged (Zanisi et al., 
1987). However, Yu et al. (1994) recently demonstrated that prolonged treatment (24 
h) with Ant 27 increased GnRH content, but not GnRH mRNA levels, suggesting that 
either the translational efficiency of GnRH mRNA or the processing of GnRH precursor 
protein may be under autofeedback regulation. 
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Figure 18: Effect of different concentrations of Ant 27 on cellular GnRH content of 
GT1-7 cells. 
GnRH cellular content was determined after GT1 -7 cells were co-
incubated with Ant 27 for 30 min or 18 h. No significant difference to 
control groups (no antagonist) was observed (n=S for each group). 
Coupled with the anatomical evidence for direct contacts between GnRH neurons, the 
present findings clearly support a physiological role for a negative ultrashort loop 
feedback within the GnRH neuronal system. This mechanism may be a consequence 
of the ability of the GnRH autoreceptor to modulate the frequency and amplitude of 
the spontaneous GnRH release from these cells (Krsmanovic et al., 1993). 
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4: CONCLUDING DISCUSSION 
The neuroendocrine hypothalamus has been intensively studied using whole animals 
and tissue slices. However, direct analysis of the secretory activity of GnRH neurons 
has proved to be profoundly difficult due to their scattered topography and the physical 
inaccessibility of the hypothalamo-hypophyseal portal plexus. The recent development 
by Mellon et al. (1990) of GnRH-secreting neuronal cell lines (GT1-1, GT1-3 and GT1-
7), derived by directed tumorigenesis in transgenic mice, provides the first in vitro 
model for the study of neural regulation of a pure population of GnRH neurons. 
The extensive network of GnRH neurons and other neural elements act together to 
process a myriad of signals which influence the pulsatile release of GnRH into the 
pituitary portal circulation. Until recently, the anatomical, cellular, and molecular basis 
of the GnRH pulse generator remained largely unknown. Likewise, little is known of 
the inter- and intracellular routes through which the activity of GnRH pulse generator 
is regulated in vivo. These GnRH neuronal cells have provided a system in which to 
unravel the complex molecular and cellular mechanisms underlying GnRH gene 
expression, processing, and secretion. In addition, the cellular mechanisms 
responsible for the intrinsic rhythmic activity generating episodic GnRH release remain 
intriguing and important questions that should be addressable in GT1 cells (Martinez 
de la Escalera et al., 1992a). 
Recent studies have found pulsatile GnRH secretion to be an intrinsic property of 
GnRH neuronal networks and to depend on Ca2+ influx for its maintenance (Mellon 
et al., 1990; Martinez de la Escalera et al., 1992a; Wetsel et al., 1992; Krsmanovic et 
al., 1992). In addition to implying the existence of a single-cell oscillator, the 
observation of discrete pulses suggests the existence of a mechanism for 
synchronization of GnRH release from many neurons. This may be mediated either 
by synaptic mechanisms or electronic coupling via gap junctions (Wetsel et al., 1992). 
Conceivably, a diffusible mediator such as GnRH itself, GAP or GAL may be involved. 
In accord with this, GnRH neurons in vitro are able to reorganize into interconnected 
clusters, forming contacts between their cell bodies and between developing and 
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mature processes (Li posits et al., 1991 ). GnRH in axons of local circuit neurons could 
serve to co-ordinate GnRH secretion from individual cells and, thereby, orchestrate 
functions in vivo as diverse as the onset of puberty, the timing of ovulation, and the 
duration of lactational infertility. In addition, the synaptic connections could serve as 
a neuronal ultrashort loop feedback channel for the self-regulation of GnRH-
synthesizing neurons. In turn, the autofeedback control may be differently regulated 
to achieve the variety of responses necessitated by the GnRH neurosecretoy system. 
The complexity of GnRH action in perifused GT1-7 cells was recently highlighted by 
Krsmanovic et al. (1993). Their results suggest that the feedback effects of GnRH 
include both positive and negative components that exert an integrated action on its 
neurons and contribute to the operation of the GnRH pulse generator. However, in 
the present studies co-incubation of Ant 27 with static GT1 -7 cells resulted in 
enhanced basal GnRH release. This result implies that GnRH by binding to 
autoreceptors in GT1-7 cells, negatively controls its own secretion. 
Presynaptic inhibition of neurotransmitter release may involve either an enhancement 
of a K+ conductance, reducing the ability of action potentials to invade the terminal, or 
inhibition of Ca2+ currents, directly reducing the influx of Ca
2+ which is a prerequisite 
for transmitter release (Nicoll, 1988; Tsien et al., 1988). Thus, the apparent paradox 
can be resolved by a model in which early activation of the GnRH receptor by the 
agonist causes an elevation of [Ca2+]i (by releasing intracellular Ca2+ stores), resulting 
in enhanced GnRH release. The subsequent suppression of release is due to agonist-
induced inhibition of Ca2+ entry (Krsmanovic et al., 1993). Further the [Ca2+]i response 
to GnRH was rapidly inhibited by prior addition of a potent GnRH antagonist. It is 
proposed that the enhanced GnRH release observed in the presence of Ant 27 is 
probably due to the removal of the inhibitory effect of GnRH on its own release. This 
may be accomplished by preventing the GnRH-induced inhibition of Ca
2+ influx. As 
a result, Ca2+ influx may increase. In addition, since K+- and forskolin-induced GnRH 
release is dependent on influx of extracellular Ca
2+, this hypothesis may explain the 
enhanced GnRH release by these secretagogues observed in the presence of Ant 27. 
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It would be reasonable to assume that activation of the negative ultrashort loop 
feedback is triggered once a certain threshold for GnRH concentrations is reached. 
This threshold is most likely rapidly attained in the static culture system. In this 
scenario the negative autofeedback would then be responsible for maintaining the 
steady-state levels required for basal activity. Furthermore, the juxtaposition of axon-
like processess to cell bodies (mimicking the pattern of axe-somatic communication) 
provides the anatomical support for negative feedback effects on pulsatile GnRH 
secretion during periods of basal activity (Liposits et al., 1991 ). Given the high degree 
of similarity between GT1-7 cells and GnRH neurons, the present data argues in 
favour of an inhibitory role of GnRH on its own secretion. However, further studies are 
necessary to identify precisely which cellular effector system(s) mediate the 
physiological actions of GnRH in GT1-7 cells. 
An additional hypothesis involves the co-localization of GAL with GnRH in the GnRH 
neurons. Marks et al. (1993) propose a model which predicts that GAL expression in 
GnRH neurons is a prerequisite for producing the distinctly pulsatile pattern of GnRH 
release. GAL could most effectively alter GnRH secretion by acting directly on the 
GnRH neurons from which it is released. The degree of influence GAL has on GnRH 
release would be related to its concentration at the nerve terminal, which in turn, may 
depend on its relative rate of biosynthesis. Factors controlling this biosynthetic rate 
include ovarian steroids, which may act either directly on the GnRH neuron or 
indirectly on other neurons that provide afferent input to GnRH neurons. Although this 
model focuses on the effect of GAL expression in GnRH neurons on GnRH release, 
the precise functional role of GnRH autoregulation and the conditions under which it 
becomes operational remain to be defined. 
Due to the intrinsic pulsatile nature of the GnRH secretory process it is obvious that, 
in addition to autoregulation, inhibitory as well as facilitatory pathways are required to 
coordinate such a delicate and precise secretory rhythm. The neuronal circuitry 
formed by the multiple neurotransmitter and neuromodulatory systems known to 
innervate GnRH neurons may form additional neural networks that are able to modify 
the frequency and amplitude of an inherent pulsatile rhythm. For example, changes 
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in inhibitory neural inputs from EOP and GABA neurons have been proposed as 
inhibitors of GnRH neuronal activity (Masotto et al., 1989; Rasmussen et al., 1990). 
Furthermore, hypophysiotropic peptidergic neurons have been shown to influence the 
activity of other intrahypothalamic peptidergic cells and to be themselves under 
peptidergic control. For instance, synaptic contacts have been demonstrated between 
SS and GRF, POMC and GnRH, and NPY and VIP-containing neurons. Interestingly, 
all of these cell types have been shown to synapse upon themselves indicating that 
they too are capable of synchronization and/or autoregulation. Taken together, these 
morphological data provide evidence for multiple levels of cross-talk between 
hypothalamic peptidergic neurons and indicate that such interactions may play a role 
in the regulation of the hypothalamo-hypophyseal axis (Beaudet, 1990). To date, the 
factors that have been shown to directly release GnRH from GT1-7 cells include the 
following. NE, Endothelin-3, NPY and a GABAA agonist all significantly stimulated 
GnRH release from static GT1 cultures (Martinez de la Escalera et al., 1992b; Favit 
et al, 1992; Findell et al., 1993; Moretto et al, 1993; Besecke et al, 1993). 
Studies by Bourguignon et al. (1990b) lead them to suggest that the increased 
frequency of pulsatile GnRH secretion at the onset of puberty may be related to a 
reduced sensitivity of the hypothalamic pulse generator to an inhibitory autofeedback. 
This hypothesis is based on the observation that the inhibitory autofeedback of GnRH 
on pulsatility appears to be reduced in potency by NMDA. Interestingly, recent studies 
have indicated that GLU (via NMDA and AMPA/kainate receptors) can stimulate GnRH 
secretion by acting directly on GT1-7 cells {Spergel et al., 1994). Results, in part, 
supported by work presented in section 2.3 demonstrating L-GLU enhanced GnRH 
release. As stated by Bourguignon et al. (1990b), "It is likely that the target of the 
autofeedback and the primary event of hypothalamic maturation at onset of puberty 
are closely related. This is why it is critical to further study autoregulation which can 
provide a clue of the central mechanism of puberty." Hence, an analysis combining 
the activation of the GLU receptor subtypes with GnRH analog studies in GT1-7 cells 
would provide essential information in this regard. 
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Further studies to elucidate the mechanism of autofeedback would include determining 
the effector systems that are coupled to the receptor and also, the location of the 
GnRH receptor (soma, dendrites, or axon?). The synapse-like contacts could perform 
a negative-feedback role to regulate not only the amount of GnRH released but also 
the molecular forms secreted. Since the cells also contain GAP, they will be valuable 
in studying the biosynthesis and processing of the GnRH molecule and its products. 
Also differences in the GAP/GnRH ratio in vesicles may influence the autofeedback 
mechanism. However, pro-GnRH processing may be more complete under perifusion 
than under static culture conditions. Indeed, perifusion serves to remove products 
(e.g., GnRH and GAP) from the cell that could feedback to inhibit some of the 
processing enzymes. For this reason, the perifusion system may provide a better 
physiological model to study GnRH secretion and processing than the conditions 
imposed under the static culture conditions (Wetsel et al, 1992). 
In addition to numerous observations that steroids influence the activity of the 
neuroendocrine systems involved in the regulation of GnRH release (1.2.3), steroids 
seem to be critical for organizing and reorganizing the neuronal circuitary in the CNS 
(Matsumoto, 1991 ). These cells were, however, maintained in an environment 
relatively free of steroid hormone influences. Differences in receptor densities and/or 
receptor subtypes may exist when these cells are maintained under a different 
steroidal hormone milieu. GT1-7 cells cultured in isolation, almost certainly, represent 
only one potential state of a highly regulated cell. However, to date data obtained 
from experiments with GT1 cells are in good agreement with findings in animals, and 
they appear to be an important tool in furthering our knowledge concerning the 
neuroendocrine regulation of reproduction and the characteristics of an isolated CNS 
neuron. 
To conclude: 
" When you think about brain activity its correct to think about emergent properties at 
higher levels that depend on lower level phenomena in the system" 
Patricia Churchland, Neurophilosophy. 
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Thus, the evidence presented for the existence of an ultrashort feedback at the level 
of the GnRH neuron is a significant step towards gaining insight into the mechanics 
of the system which has the GnRH pulse generator as its emergent property. 
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